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ABSTRACT 
 
Amyloid fibrils are a misfolded state formed by many proteins when subjected to denaturing conditions. 
Their constituent amino acids make them an excellent target for enzyme immobilisation and their 
strength, stability and nanometre size are attractive features for exploitation in the creation of new 
bionanomaterials. 
 
The aim of this thesis was to functionalise amyloid fibrils by conjugation to glucose oxidase (GOD). 
GOD is a relatively stable glycoprotein that catalyses the oxidation of glucose and the release of hydrogen 
peroxide. The consumption of glucose can be measured to assess glucose levels, and the release of 
hydrogen peroxide is cytotoxic to cells and is thus an effective antibacterial agent. Three methods of 
attachment were used: cross-linking using glutaraldehyde, periodate oxidation of the glycoprotein shell, 
and cross-linking using glutaraldehyde following deglycosylation. GOD retained activity upon 
attachment by all three methods. These attachment methods were assessed using electrophoresis, 
centrifugation, sucrose gradient centrifugation and TEM. Gel electrophoresis indicated a high degree of 
cross-linking and TEM showed no significant change of fibril morphology upon cross-linking. 
Centrifugation experiments suggested a non-covalent interaction was occurring between amyloid fibrils 
and GOD, and a covalent attachment was occurring upon addition of glutaraldehyde. Sucrose gradient 
centrifugation provided increased separation of cross-linked material compared to other separation 
methods, and showed greater cross-linking to crystallin amyloid fibrils than insulin fibrils. Cross-linking 
native GOD using glutaraldehyde was chosen for further experiments, as it was found to be most 
effective for GOD attachment to amyloid fibrils. 
 
The resulting functionalised enzyme scaffold was then incorporated into a model poly(vinyl alcohol) 
(PVOH) film, to create a new bionanomaterial. The distribution of the functionalised fibrils through the 
film was characterised using SEM and confocal microscopy, where film components were found to be 
unevenly dispersed. The antibacterial effect of the functionalised film was then tested on E. coli and the 
antifungal effect of the film was tested on Fusarium, Rhizopus and Penicillium. Growth of E. coli was 
inhibited around functionalised film circles, demonstrating the incorporation of GOD antibacterial 
activity into the PVOH film. However, no growth inhibition of fungal species was observed.    
 
This work is of significance as it demonstrates the ability to convert a waste material, bovine lens 
crystallin, to high value protein nanofibres and incorporate functionality via GOD attachment. The 
incorporation of the GOD-functionalised amyloid fibrils into PVOH provides an excellent ‘proof of 
concept’ model for the creation of a new bionanomaterial using a functionalised amyloid fibril scaffold. 
Future development of this model system has the potential to lead to the production of a novel biomaterial 
for use in food packaging due to the antimicrobial properties of GOD. 
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1. CHAPTER ONE – INTRODUCTION  
 
 
Amyloid fibrils are stable proteinaceous nanofibres with potential applications in 
bionanotechnology. Their constituent amino acids make them an excellent target for enzyme 
immobilisation. The ability to attach the enzyme glucose oxidase (GOD) to amyloid fibrils to 
create functionalised amyloid fibrils was investigated and the functionalised amyloid fibrils 
were then incorporated into a film system. The role of the amyloid fibrils in the film system was 
to act both as a scaffold for enzyme immobilisation, and to add tensile strength to the film. 
 
 
1.1 Context 
 
Can we use amyloid fibrils as a nanoscaffold for enzyme immobilisation? An amyloid fibril is a 
misfolded state formed by many proteins when subjected to denaturing conditions, such as low 
pH and high temperature (Brange et al. 1997a). This protein fold is remarkable due to its high 
stability at a wide pH range, a variety of temperatures and on exposure to proteolytic enzymes. 
Amyloid fibrils are also very strong, with an estimated strength similar to the strength of spider 
silk, which is five times that of steel (Kenney et al. 2002; Waterhouse and Gerrard 2004). 
Amyloid fibril formation by two proteins, bovine insulin and bovine lens crystallin, and 
immobilisation of GOD onto these amyloid fibrils was investigated in this thesis.  
 
In biotechnology, useful properties for enzymes are high stability, use of a commercially 
important analyte, and high turnover number (Wilson and Turner 1992). GOD catalyses a 
biochemically important reaction that involves the consumption of glucose and the release of 
hydrogen peroxide. Hydrogen peroxide is cytotoxic to cells, making GOD an effective 
antimicrobial agent, and consumption of glucose by GOD is useful for measuring glucose levels 
(Rodriguez-Nogales 2004). GOD is also an extremely stable enzyme, as it is stable between a 
pH range of 2 and 8, and at temperatures up to 62 °C (Wilson and Turner 1992; Gouda et al. 
2003). These features make the enzyme ideal for applications such as measuring glucose 
concentration and as an antimicrobial agent. Measurement of glucose concentration is important 
for determination of blood glucose levels in diabetic patients, and also in the beer and wine 
industry for measuring glucose levels during the fermentation process (Wong et al. 2008).  
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The functionalised amyloid fibrils were then incorporated into a film system. Poly(vinyl 
alcohol) (PVOH) is an ideal film system for this investigation, as it is inexpensive and readily 
available commercially, and provides an environment similar to that of water for the enzyme 
(Wong and Abdul-Aziz 2008). The ability to functionalise amyloid fibrils by conferring 
enzymatic activity and incorporate them in a film system provides an exciting opportunity for 
the creation of new bionanomaterials.  
 
 
1.2 Introduction to amyloid fibrils 
 
Amyloid fibril formation is the assembly of protein monomeric units into fibrils with a high β-
sheet content (LeVine III 1999). Amyloid, originally meaning starch-like, refers to the protein 
deposits that were reminiscent of starch when first observed (Cohen and Calkins 1959; Hamley 
2007). Amyloid fibrils are a protein fold associated with numerous disease states, such as 
Parkinson’s and Alzheimer’s diseases (Chiti and Dobson 2006). Their role in disease is thought 
to be due to either loss or gain of function of the protein upon forming amyloid fibrils (Luheshi 
et al. 2008). For example, the prion protein gains neurotoxicity when misfolded, which leads to 
the misfolding of surrounding proteins in the brain. This results in neurodegenerative disease, 
although the precise reasons for this are unknown (Winklhofer et al. 2008). Conversely, the 
amyloid β-protein loses its normal cellular function when misfolded and forms deposits of 
insoluble protein in the neurons of the brain, which also results in neurodegenerative disease 
(Winklhofer et al. 2008). It is thought that the protofibril is the toxic species in disease, rather 
than the mature folded amyloid fibril (Chiti and Dobson 2006; Cherny and Gazit 2008). Nature 
has also exploited the amyloid fibril fold in some organisms, for example in the bacterium 
Escherichia coli, amyloid fibrils are found on the surface as a part of the bacterial biofilm (Gras 
2007; Jahn and Radford 2008). Class I hydrophobins in fungi and chaplains in Gram-positive 
streptomycetes are amyloidogenic proteins which assist branching hyphae to reduce surface 
tension at the water-air interface (Kwan et al. 2006; Cherny and Gazit 2008).  Amyloid fibrils 
are also utilised in the egg envelopes of several fish and insects to protect the egg against 
chemical and physical stresses (Cherny and Gazit 2008). This shows the remarkable natural 
versatility of function of the amyloid fold.  
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Figure 1.1 
Protein misfolding states. Following synthesis of proteins by the ribosome (not shown), the unfolded 
protein quickly establishes a native folded state, due to interactions between constituent amino acids and 
their environment. The native state can then associate with more native proteins to form one of two 
different structures, a functional oligomer (also known as a globular protein) or a functional fibre. The 
establishment of a native state is a dynamic pathway and the native state can unfold and fold in 
physiological conditions. If this pathway is disrupted, the protein may misfold, leading to the formation of 
disordered aggregate, the degradation of the protein into fragments, or the formation of prefibrillar 
species. Prefibrillar species associate to form amyloid fibrils via β-structured aggregates called 
protofibrils. Adapted from Dobson (2003), Chiti and Dobson (2006) and Murphy and Kendrick (2007). 
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Many polypeptides can achieve the amyloid folding motif as a nearly ubiquitous alternative 
folded state, despite having different amino acid sequences and native folds (Rochet and 
Lansbury 2000; Wetzel et al. 2007). In fact, all proteins are thought to be able to access the 
amyloid fibril fold (Chiti and Dobson 2006). However, different proteins have different 
propensities for forming amyloid fibrils. Amyloid fibril forming propensity is governed by 
hydrophobicity, net charge, propensity of constituent amino acid residues to form β-sheets, and 
the presence of aromatic residues in the polypeptide (Gras 2007). For many proteins, fibril 
formation can be induced at high temperature and low pH, as these conditions provide the 
enthalpic driving force required to disrupt proteins from their native fold (Brange et al. 1997a) 
(Figure 1.2). In these denaturing conditions, non-covalent interactions such as hydrogen 
bonding can still occur within the polypeptide, which stabilise the amyloid fibril structure (Chiti 
et al. 1999). Amyloid fibrils are thus insoluble and stable, achieving their stability through both 
hydrophobic and electrostatic forces, in a similar way to globular proteins (Wetzel et al. 2007) 
(Figure 1.2). 
 
Figure 1.2 
A combined schematic energy landscape for protein folding and aggregation. The simple folding funnel 
(light grey) can describe the energy changes involved in establishing the native state of a polypeptide. 
The stability of the native state is indicated, where there is a large energy change needed to disrupt the 
native state. This simple folding funnel becomes more complex (dark grey) when intermolecular protein 
association is considered. The remarkable stability of the amyloid fibril fold is represented by the largest 
energy change needed to disrupt this fold. Adapted from Jahn and Radford (2008). 
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1.3 Amyloid fibril structure 
 
Amyloid fibrils have a diameter ranging from 5 nm for small fibrils, to 10 nm for larger fibrils, 
and are generally long, straight, rigid and un-branched (Rochet and Lansbury 2000; Cherny and 
Gazit 2008). The tertiary structure of the fibrils consists of β-strands perpendicular to the fibril 
axis in a ‘cross-β’ structure (Rochet and Lansbury 2000; Hamley 2007). This cross-β structure 
has been observed using infrared dichroism spectroscopy and X-ray diffraction (Sunde et al. 
1997). Two steps govern the formation of amyloid fibrils, these are the rate of fibril growth and 
the rate of fibril nucleation (Lomakin et al. 1996). The formation of the β-rich nucleus is a 
thermodynamically unfavourable process, compared to the elongation process, which proceeds 
rapidly upon formation of the fibril nucleus (Jahn and Radford 2008). During the elongation 
process, the β-sheets self-assemble into protofilaments, which, in turn, coil into protofibrils 
(Hamley 2007) (Figure 1.3). Assembly of more than two protofilaments into a protofibril is 
considered a mature fibril (Groenning et al. 2007). In order for protofibril coiling to occur, there 
must be slight changes in the β-sheet, which is an intrinsically flat structure (Jiménez et al. 
2002). For proteins with propensity for aggregation, such as insulin, the elongation process may 
occur within a few hours, whereas proteins with a lower amyloid propensity may take a lot 
longer (Gras 2007). It has recently been predicted that even the α-helix regions of polypeptides 
have β-sheet propensity, indicating that the protein must be partially unfolded from its 
secondary structure during amyloid fibril formation (Jahn and Radford 2008). 
Figure 1.3 
Amyloid fibril protofilament structure. During the nucleation step of amyloid fibril formation, β-sheet 
rich pre-fibrillar species associate to form protofilaments, as shown in the protofilament structural motif 
(left inset). This structural motif is repeated to form a long protofilament during the elongation step of 
fibril formation (centre inset). The protofilaments then coil together, forming an amyloid fibril (right). 
Adapted from the “General amyloid structural motif”, PDB file 2nnt (Ferguson et al. 2006) and the 
amyloid fibril model (Jiménez et al. 2002). 
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1.4 Characterisation and purification of amyloid fibrils 
 
Amyloid fibrils display a distinct X-ray diffraction pattern, consistent with a cross-β structure, 
which has become one of the accepted characteristics of amyloid fibril formation (Sunde et al. 
1997). This distinct pattern also suggests that the amyloid fibrils share a degree of structural 
similarity, despite being formed from different polypeptide chains (Sunde et al. 1997). After X-
ray diffraction, the best methods of fibril characterisation to date involve microscopic 
techniques. Amyloid fibrils have been visualised both with transmission electron microscopy 
(TEM) and atomic force microscopy (AFM) (Besteman et al. 2003; Hrapovic et al. 2004).  
 
It is widely accepted that amyloid fibrils can be stained using histological dyes such as 
thioflavin T (ThT) and Congo red, which bind specifically to amyloid fibrils and change their 
fluorescence and absorbance properties, respectively (Klunk et al. 1989; LeVine III 1999). 
Positive identification of the formation of amyloid fibrils depends on the ability to distinguish 
between amyloid β-sheet structure from amorphous aggregates (LeVine III 1999). ThT elicits a 
distinctly different excitation and emission spectrum upon amyloid β-sheet binding, compared 
to the spectra produced by proteins with a high β-sheet content and the spectra produced by 
amyloid precursor monomers (LeVine III 1999). This is also found to be true for Congo red, 
where the dye will not stain other proteins with a minor β-sheet content (Klunk et al. 1989). The 
specificity of dye binding to amyloid fibrils is not well understood. However, several 
mechanisms have been proposed (Krebs et al. 2005). Recently, two amyloid fibril structure-
specific ThT binding sites have been proposed, either between the protofilaments forming the 
protofibrils, or between the protofibrils forming the mature fibrils (Groenning et al. 2007). One 
limitation of the dye binding analysis is that pH and ionic strength are known to affect the time 
course of ThT binding, and thus both dye binding and microscopy studies will be used in this 
thesis to indicate the presence of amyloid fibrils (LeVine III 1999).  
 
Exposure of amyloid fibril samples to pepsin, a protease which has high activity at low pH, will 
digest any non-fibrillar species, leaving the fibrils intact (Zurdo et al. 2001). This technique was 
developed to aid the separation of amyloid fibrils from other protein species, such as large 
aggregates, which was previously difficult to achieve using available biochemical techniques, 
such as electrophoresis or centrifugation (Zurdo et al. 2001). Separation is necessary due to 
heterogeneity introduced by the method of fibril formation in vitro, where the sample can 
contain soluble precursors that have not formed fibrils and non-fibrillar aggregates (Zurdo et al. 
2001). 
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1.5 Amyloid fibrils in bionanotechnology 
 
The amyloid fold has remarkable stability and insolubility, and thus offers great potential for 
biotechnology and nanotechnology (Gras 2007; Jahn and Radford 2008). This potential is 
derived from the unique properties of amyloid fibrils, specifically their ability to self-assemble 
under denaturing conditions, their inherent strength, and their ability to be functionalised by 
manipulation of their constituent amino acids (Waterhouse and Gerrard 2004; Garvey et al. 
2009). These properties have lead to the suggestion that amyloid fibrils may be used as a 
scaffold for enzyme immobilisation (Gras 2007; Cherny and Gazit 2008). This has previously 
been achieved using green fluorescent protein and enzymes such as carbonic anhydrase and 
glutathione-S-transferase (Baxa et al. 2002; Cherny and Gazit 2008). In these experiments, the 
protein of interest was attached to the C-terminus of yeast Ure2 monomers. The yeast protein 
was then fibrillised, forming an amyloid fibril with native, functional protein attached (Baxa et 
al. 2002). Cytochrome b attachment has also been demonstrated after amyloid fibril formation, 
where modified fibrils acquired cytochrome b activity and incorporated heme groups (Baldwin 
et al. 2006). 
 
 
1.6 Bovine insulin amyloid fibrils 
 
Insulin is a small polypeptide, consisting of 51 residues, with an A chain of 21 amino acid 
residues linked to a B chain of 30 amino acid residues by three disulfide bridges (Figure 1.4) 
(Whittingham et al. 2002; Devlin et al. 2006). These disulfide bridges constrain structural 
flexibility in the molecule, creating a native fold which is resistant to thermal and chemical 
denaturation (Devlin et al. 2006). The native protein is largely α-helical in structure, and exists 
as a hexamer at physiological pH (Ahmad et al. 2005). 
 
Under denaturing conditions, the termini of the component insulin chains become disordered 
and expose the helical core of the protein (Hua and Weiss 2004). This partially unfolded state is 
a prerequisite for the formation of prefibrillar species, leading to the formation of amyloid 
fibrils (Dobson 2003) (Figure 1.1). Insulin is known to form amyloid fibrils when subjected to 
high temperature and low pH (Devlin et al. 2006). When separated, both the A and B chain of 
human insulin form fibrils thus the fibril formation of whole insulin is attributed to both chains 
(Khurana et al. 2005). This has been indicated in cross-seeding experiments, where the addition 
of either A or B chain insulin fibrils seeds amyloid fibril formation in whole insulin (Devlin et 
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al. 2006). The fibrillation of insulin leads to problems in the medical industry with production, 
delivery and storage of soluble insulin for use in treating diabetic patients (Hong et al. 2006). 
This has resulted in insulin fibrils being comparatively well characterised, and thus insulin is a 
good model protein for amyloid fibril formation.  
 
Figure 1.4 
The insulin monomer. The insulin molecule is made up of two chains, chain A (red) and chain B (blue). 
Adapted from “Bovine despentapeptide insulin”, PDB file 1pid, from the crystal structure at 1.3 Å 
resolution, solved by Brange et al. (1997b). 
 
Insulin amyloid fibril formation occurs via a monomeric, partially unfolded intermediate rich in 
β-sheet structure, which is distinct from the native fold (Ahmad et al. 2005). Fibril formation 
requires the simultaneous aggregation of three to four insulin molecules via their hydrophobic 
surfaces, known as the nucleation step (Brange et al. 1997b). This nucleation step is followed 
by an extension step, to form long protofilaments. Mature insulin fibrils consist of between two 
and six protofilaments twisted into a fibrillar structure (Devlin et al. 2006) (Figure 1.3). The 
mature fibril measures 5-10 nm in diameter and up to several microns in length (Nielsen et al. 
2001).  
 
 
1.7 Bovine crystallin amyloid fibrils 
 
Less is known about the structure of bovine crystallin fibrils in comparison to insulin fibrils; 
however, crystallins are a good source for amyloid fibrils, as eye lenses, from which crystallins 
are derived, are a waste material from the meat processing industry in New Zealand. To ensure 
feasibility for the use of amyloid fibrils in the production of new materials in 
COOH 
COOH 
NH2 
NH2 
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bionanotechnology, the amyloidogenic protein must be readily available and inexpensively 
sourced (Waterhouse and Gerrard 2004). Amyloid fibrils can be inexpensively produced from 
crude crystallin protein mixtures, and are a thus potential industrial source for protein 
nanofibres (Garvey et al. 2009).  
 
The biological role of crystallins is to provide transparent structure to the eye lens (Bettelheim 
and Chen 1998). There are three constituent crystallins in the mammalian lens, α-, β-, and γ-
crystallin (Carver et al. 1996). α-Crystallin, the most abundant lens protein, has two subunit 
components and exists as a large aggregate (approximately 800 kDa), β-crystallin has many 
subunits and is found as a smaller aggregate, and γ-crystallin is a monomer (Carver et al. 1996). 
 
All three crystallins have been shown to form amyloid fibrils when subjected to conditions of 
high temperature and low pH (Meehan et al. 2004). Crystallin fibril formation in the eye lens is 
seen in age-related cataracts, where crystallin transparency is lost upon fibrillation (Carver et al. 
1996). The formation of crystallin amyloid fibrils can be observed using TEM, X-ray fibre 
diffraction, and dye binding by Congo red and ThT, although the ThT method is compromised 
by high background binding to native crystallins (Meehan et al. 2004; Meehan et al. 2007; 
Garvey et al. 2009). 
 
 
1.8 Glucose oxidase 
 
Glucose oxidase (GOD) is an oxidoreductase enzyme found in some species of fungi such as 
Aspergillus niger and Penicillium amagasakiense and is also found in honey (Fuglsang et al. 
1995). The natural function of GOD in vivo is proposed to provide protection against predators 
and other invasive species for fungi, and it acts as a natural antibiotic in honey (Vartiainen et al. 
2005). GOD catalyses the oxidation of β-D-glucose by molecular oxygen, to hydrogen peroxide 
and glucono-1,5-lactone, which spontaneously hydrolyses to gluconic acid (Leskovac et al. 
2005). The oxidation of β-D-glucose to glucono-1,5-lactone involves the reduction of the FAD 
(flavin adenine dinucleotide) cofactor to FADH2. The reduced FADH2 is oxidised by molecular 
oxygen, which is itself reduced to hydrogen peroxide. These reactions are coupled together to 
give an overall reaction shown in Scheme 1.1 (Leskovac et al. 2005). 
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Scheme 1.1 
The overall reaction catalysed by the GOD enzyme. During the oxidation of glucose to gluconic acid by 
GOD, the FAD cofactor of GOD is reduced to FADH2 and molecular oxygen is reduced to hydrogen 
peroxide. This leads to the re-oxidation of the cofactor and allows the reaction to cycle. Adapted from 
Lescovac et al. (2005). 
 
The redox active site of the enzyme is buried in the centre, close to the FAD cofactor. Other 
hexose sugars such as α-D-glucose, mannose and galactose form either fewer bonds or 
unfavourable contacts with neighbouring amino acids, explaining why the enzyme is specific 
for β-D-glucose (Wohlfahrt et al. 1999). 
 
GOD is a slightly elongated, structurally rigid, flavin-containing glycoprotein, consisting of 583 
amino acid residues (Wilson and Turner 1992; Hecht et al. 1993; Leskovac et al. 2005). It is a 
homodimer made up of two identical subunits (O'Malley and Weaver 1972), with a molecular 
weight of approximately 80 kDa each (Leskovac et al. 2005). GOD contains both α-helix and β-
sheet structures. The active site contains three main active site residues, His516, His559 and 
Glu412 (Figure 1.5) (Leskovac et al. 2005). The dimer contains two disulfide bridges, one per 
monomer, though the significance of these bridges is still unknown (Wilson and Turner 1992). 
Each monomer also contains a flavin adenine dinucleotide (FAD) redox centre, which 
undergoes a two-electron transfer reaction (Figure 1.5) (Fairman and Ǻkerfeldt 2005).  
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Figure 1.5 
Important structural features of the glucose oxidase monomer from Aspergillus niger. The monomer 
contains one FAD molecule (blue) and three important active site residues, two histidines (red) and a 
glutamine (yellow). Adapted from “Glucose oxidase from Aspergillus niger”, PDB file 1cf3, solved by 
Hecht et al. (1993) and Wohlfahrt et al. (1999). 
 
Upon binding of glucose, there is hydride and proton transfer from glucose to the FAD and 
His516 respectively (Leskovac et al. 2005). Proton transfer then occurs from His516 to 
molecular oxygen (Leskovac et al. 2005). His559 is hydrogen bonded to Glu412, leaving 
His516 exposed to the solvent (Leskovac et al. 2005).  
 
The native enzyme has a glycoprotein shell which encases the protein core (Wilson and Turner 
1992). The glycoprotein shell usually consists of 190 mannose residues and 16 N-
acetylglucosamine residues, which are N- or O-glycosidically linked to the enzyme (Kalisz et al. 
1991; Leskovac et al. 2005). These residues account for about 24% of the enzyme’s molecular 
weight, depending whether glycosylation isoforms of the enzyme are present (Kalisz et al. 
1991). According to the crystal structure of the deglycosylated enzyme at 2.3 Å resolution, the 
GOD monomer is a compact spheroid with the approximate dimensions of 60 Å x 52 Å x 37 Å 
and the GOD dimer has the approximate dimensions of 60 Å x 52 Å x 77 Å (Hecht et al. 1993). 
Scanning tunnelling microscopy (STM) images of the GOD dimer show the two subunits to be 
arranged in a butterfly shape, with two symmetric wings and a depressed bridge in the middle 
(Chi et al. 1994; Losic et al. 2002). Similarly, atomic force microscopy (AFM) has been used to 
visualise individual GOD molecules (Losic et al. 2004). 
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GOD, with the non-glycosylated recombinant enzyme being slightly less thermostable than 
native GOD from P. amagasakiense (Witt et al. 1998). Changes in glycosylation have been 
shown to directly affect the amount of hydrogen tunnelling in the hydrogen transfer step of the 
GOD-catalysed reaction (Kohen et al. 1997). Increased tunnelling is correlated with a lower 
enthalpy of activation (Kohen et al. 1997). It has since been concluded that any protein 
modification to the surface of the GOD molecule affects hydrogen transfer at the active site; 
however, the reason behind this is poorly understood (Seymour and Klinman 2002).  
 
Figure 1.7 
The effect of pH on GOD. GOD forms its native dimeric state between a pH of 2 and 10. Below pH 2, the 
enzyme becomes denatured, and above pH 10, the enzyme forms a partially unfolded dimer. The partially 
unfolded dimer will resume the native dimeric state when the pH is lowered to 6. The deglycosylated 
enzyme behaves slightly differently, with the formation of a compact dimer at a pH above 10 (Sohail 
Akhtar and Bhakuni 2003). 
 
GOD is stable at 0 °C for two years after lyophilisation (Wilson and Turner 1992). In a water-
ethanol mix with an ethanol content of above 90%, the enzyme has a greater stability than its 
stability in water, and still retains 100% of its activity after 30 minutes at room temperature 
(Lukachova et al. 1997). The enzyme is active at a pH range of between 2 and 8 and is very 
resistant to proteolysis (Wilson and Turner 1992). Dissociation of the subunits can only occur 
under denaturing conditions, and results in the loss of FAD to form an apo-enzyme (Leskovac et 
al. 2005). Thus the GOD enzyme is very stable relative to other enzymes. It has also been 
reported that both the deglycosylated and glycosylated enzyme have similar structural features 
Partially Unfolded 
Dimer 
Native GOD 
(Dimer) 
Deglycosylated 
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Denatured Protein 
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at physiological and acidic pH, but show different structural features at alkaline pH (Figure 1.7) 
(Sohail Akhtar and Bhakuni 2003). Recent thermal inactivation experiments show an increase in 
thermal inactivation and the loss of the FAD cofactor from the enzyme at 59 °C, with the 
enzyme retaining its secondary and tertiary structure at temperatures up to 62 °C (Gouda et al. 
2003). This indicates that loss of the FAD cofactor is the important factor for initial thermal 
inactivation, rather than loss of secondary and tertiary structure (Gouda et al. 2003).  
 
 
1.9 GOD assay methods 
 
Hydrogen peroxide produced from the GOD-catalysed reaction has been reacted with o-
dianisidine to produce a brown product in colorimetric diagnostic kits for the determination of 
glucose in the blood (Wilson and Turner 1992). Progression of the GOD-catalysed reaction can 
also be monitored using the intrinsic fluorescence increase of the FAD cofactor as it is reduced 
(De Luca et al. 2007). There are also commercially available kits that use the fluorescent agent 
resorufin (commercially known as Amplex Red (Invitrogen) or Ampiflu Red (Sigma)) to 
measure the progress of the GOD-catalysed reaction (Zhang et al. 2004). Resorufin was used in 
this thesis, as it is an extremely quick and sensitive method for assessment of GOD activity. The 
resorufin reaction also produces a fluorescent pink product, which is visible both by eye and by 
fluorescence measurement. 
 
 
1.10 GOD immobilisation 
 
Before an enzyme can be used effectively in many applications, it must first be immobilised. 
Immobilisation allows the enzyme to be reused, allows recovery of the enzyme and its product 
and more control over the enzymatic reaction, such as control of termination of the reaction 
(Krajewska 2004). Enzymes may be immobilised by a variety of methods, which may be 
broadly described as physical, where weak interactions between support and enzyme exist, such 
as entrapment within microgels and adsorption, and chemical, where covalent bonds are formed 
with the enzyme, such as cross-linking (Krajewska 2004). In some cases, such as with GOD, the 
enzyme has greater activity upon immobilisation, which may be due to the stabilisation of the 
active conformation of the enzyme by the supporting medium (Tiller et al. 2002).  
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The most common method of GOD immobilisation to date has been cross-linking via lysine 
residues on the GOD enzyme. The dimeric glycosylated GOD enzyme has 30 lysine residues in 
its sequence, with 24 of these residues located on the surface of the polypeptide (Baszkin et al. 
1997). Around five of these surface lysine residues are available for cross-linking, as shown by 
covalently reacting the residues with N-hydroxysuccinimide (NHS) (Kriechbaum et al. 1989; 
Frederick et al. 1990; Baszkin et al. 1997). This indicates that some lysine residues on the 
surface of the enzyme are still accessible and are not completely covered by the glycoprotein 
shell. GOD has been previously cross-linked both to itself, in order to improve intramolecular 
stability, and to structures such as electrodes and films, for use in biosensing (Kozulic et al. 
1987; Delvaux and Demoustier-Champagne 2003; Gade et al. 2006). GOD has been cross-
linked using glutaraldehyde (GA) extensively in previous work (Ahmad et al. 2001; Sohail 
Akhtar and Bhakuni 2003). GA reacts with the free amino group of lysine (and arginine) 
residues on the surface of GOD (Figure 1.6). The exact mechanism remains unknown, and 
could progress via a Schiff base intermediate, although this would require further reaction 
and/or the presence of a reducing agent in order to form a stable covalent attachment. Another 
possible mechanism is the formation of a pyridinium cross-link, which is outlined in Scheme 
1.2 (Meade et al. 2003).    
 
In other research, GOD has been immobilised on metallic nanotubes using GA and a mixture of 
NHS and 1-ethyl-3-(3-diaminopropyl)carbodiimide hydrochloride (EDC), which cross-links the 
GOD enzyme in an analogous way to GA chemistry, via the lysine residues on GOD (Delvaux 
and Demoustier-Champagne 2003). Some research has also combined entrapment with cross-
linking. This is achieved by entrapping the GOD in poly(vinyl pyridine), and then using a 
method such as exposure to UV light to cross-link the pyridine molecules (Gregg and Heller 
1990).  
 
GOD was most thermostable when immobilised using GA-activated supports (Betancor et al. 
2006). Cross-linking of GOD to carbon nanotubes has also been achieved with carbodiimide 
(Lin et al. 2004). Ferrocene-modified polypyrrole was also used to immobilise GOD (Heller 
1992). Some research that uses the entrapment immobilisation method alone involves the use of 
cross-linked polyacrylamide microgels in the immobilisation of GOD (Retama et al. 2003). 
Using scanning electron microscopy, Retama et al. (2003) were then able to visualise the 
difference between microgels containing cross-linked enzyme and those without, based on size.  
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Because GOD is a glycoprotein, conventional protein cross-linking techniques may not be the 
most effective method. Cross-linking the carbohydrate shell of GOD has been achieved by 
oxidising the constituent sugar molecules (Kozulic et al. 1987). This method is not ideal, 
however, due to the lack of data surrounding the exact composition of the glycoprotein shell of 
GOD, due to the necessary cleavage of the glycoprotein shell in order to get a crystal structure 
(Kalisz et al. 1991). 
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Scheme 1.2 
Formation of a pyridinium cross-link with glutaraldehyde. Glutaraldehyde reacts with lysine residues 
on the GOD enzyme. Following the completion of several steps, a pyridinium cross-link is formed. 
Adapted from Meade et al. (2003). 
 
 
1.11 Fibril cross-linking 
 
As mentioned previously in Section 1.5, amyloid fibrils have the potential to be functionalised 
due to the reactivity of their constituent amino acids. The ability of amyloid fibrils to be cross-
linked via these amino acids can be exploited as a method of enzyme immobilisation. Due to the 
fact that amyloid fibrils are of a high molecular weight and associate with each other, they are 
difficult to separate using standard protein separation methods, such as gel electrophoresis and 
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chromatography. It is therefore difficult to tell whether the enzyme has been cross-linked to the 
amyloid fibrils, or whether it is non-covalently associated with the fibrils. Microscopy currently 
offers the most convincing results for assessing enzyme attachment to carbon nanotubes. This is 
shown in research using atomic force microscopy (AFM) (Besteman et al. 2003). This research 
involved the use of single-walled carbon nanotubes (SWCNTs), which are long, thin tubes. The 
height of an unmodified SWCNT is constant over the length of the nanotube and slightly below 
one nanometre. Besteman et al. attached GOD to the outside of the SWCNT using 
glutaraldehyde chemistry, and compared the height of this functionalised nanotube to the 
unmodified nanotube. The functionalised SWCNT with immobilised GOD had a larger height 
measuring 2-4 nm. The GOD dimer has the dimensions 6 x 5.2 x 7.7 nm, as determined by 
crystallography (Section 1.8) (Hecht et al. 1993). However, this extra height is in agreement 
with the height of dehydrated GOD in addition to the height of the nanotube (Besteman et al. 
2003). This indicates that enzyme immobilisation onto carbon nanotubes can be viewed using 
AFM, and suggests that this functionalised SWCNT could be used as a model for AFM studies 
of functionalised amyloid fibrils. 
 
 
1.12 Poly(vinyl alcohol) film 
 
Nanomaterials have unusual physical and chemical properties, and thus have potential for 
applications in biosensors, biocatalysts, bioelectronics and biomedicine (Liu et al. 2007). Blends 
of synthetic polymers and biopolymers are attractive and important, because the hybrids are 
potentially applicable as biochemical, biomedical, and biodegradable chemicals (Aoi et al. 
2000). The sensitivity of a biosensor can be influenced by both the immobilisation method and 
the porosity, pore size distribution, mechanical properties, and operational stability of the host 
material used (Wong and Abdul-Aziz 2008). PVOH has useful properties for use as a 
bionanomaterial, such as good tensile strength, abrasion resistance and oxygen barrier properties 
under dry conditions (Chang and Kim 2007). PVOH has been widely used in biomaterial 
research because of its elasticity, good film-forming property, high degree of swelling in 
aqueous solutions, and water content similar to that of biological tissue (Wong and Abdul-Aziz 
2008). PVOH is also able to form a hydrogel, and this has been reported to have selective 
permeability for low molecular weight substances such as glucose, the substrate of GOD (Wong 
and Abdul-Aziz 2008).  
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Scheme 1.3 
Cross-linking of PVOH by glutaraldehyde. One possible mechanism for glutaraldehyde cross-linking of 
PVOH is given above. All steps of the reaction are reversible. Another PVOH molecule can also react 
with the other end of the glutaraldehyde in the final product (Mansur et al. 2008). 
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PVOH is an ideal material for enzyme immobilisation, as it has an abundance of hydroxyl 
groups, which provides an environment similar to the natural environment of an enzyme (Wong 
and Abdul-Aziz 2008). PVOH creates a stable environment for GOD by inhibiting the 
formation of non-functional conformations, by hydrogen bonding the H atoms of alcohol groups 
in the PVOH and the O atoms of the glycoprotein shell carbohydrate groups in GOD (Wong and 
Abdul-Aziz 2008). Despite this, PVOH films are very stiff and brittle due to high degree of 
crystallisation, and recently numerous plasticisers such as ethylene glycol have been studied and 
incorporated into films with the intention of improving the impact properties of the films 
(Chang and Kim 2007). Chemical cross-linkers such as GA have also been used in a similar 
way to introduce hydrophobicity and thus change the swelling properties of the film (Scheme 
1.3) (Mansur et al. 2008). There is evidence to suggest that addition of amyloid fibrils to PVOH 
films may increase the tensile strength of the films, thus making PVOH films an attractive 
option for use in packaging (Rao 2008). 
 
The incorporation of enzymes into PVOH films is a useful method of adding functionality to the 
films. Enzyme-film preparations are frequently unstable, due to the desorption or leeching out 
of enzyme (Gade et al. 2006). Therefore a cross-linking method via GA has frequently been 
chosen for immobilisation of the enzyme (Gade et al. 2006). GOD has been extensively 
researched for its incorporation into glucose biosensors (Liu et al. 2007). Chemical and physical 
stability of enzymes are essential requirements in enzyme sensors, as an enzyme must retain its 
activity in order to be used as a biosensor (Retama et al. 2003). GOD has been previously 
incorporated into a PVOH film, and was found to retain its activity, with an optimum activity 
level achieved at 2000 U/ml (Kumar and D'Souza 2008).  
 
 
1.13 Antimicrobial applications 
 
Antimicrobial enzymes are ubiquitous in nature, playing an important role in the defence 
mechanisms of an organism. Oxidoreductases, such as GOD, generate reactive molecules in situ 
and release these molecules into the surrounding environment as a defence mechanism. This has 
a cytotoxic effect on other organisms by destroying vital proteins (Rodriguez-Nogales 2004). 
Thus the antimicrobial effect of GOD is due to the hydrogen peroxide formed, and the 
production of gluconic acid may also influence the growth of some microorganisms by lowering 
pH levels (Rodriguez-Nogales 2004; Vartiainen et al. 2005). GOD is a naturally occurring 
enzyme in honey and originates from the hypopharyngeal glands of honey bees (Wong et al. 
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2008). The hydrogen peroxide produced in the GOD-catalysed reaction acts as a preservative 
(Taormina et al. 2001). Honey has been used for centuries as a wound dressing and these 
dressings are currently sold around the world for their antimicrobial properties (Sato and Miyata 
2000; Taormina et al. 2001). GOD has been found to have antimicrobial activity against both 
Gram-negative and Gram-positive bacteria in whole egg and Pseudomonas fluorescens, 
Acinetobacter calcoaceticum and Hansenula polymorpha in shrimp, and thus has been an 
important focus for the production of novel biomaterials with antimicrobial properties (Fuglsang 
et al. 1995; Vartiainen et al. 2005).  
 
GOD has been used in combination with lactoperoxidase in a commercial preservative system. 
Lactoperoxidase is a peroxidase enzyme found in milk, which uses hydrogen peroxide as a 
substrate. The lactoperoxidase uses hydrogen peroxide formed from the GOD-catalysed reaction 
to oxidise thiocyanate, iodine and bromine to form reactive species that have antimicrobial 
activity (Rodriguez-Nogales 2004). 
 
It has been reported that hydrogen peroxide has an inhibitory effect on the immobilised GOD 
enzyme (Bao et al. 2003). Research into this inhibition has confirmed that the inhibition is 
competitive between hydrogen peroxide and molecular oxygen, and both substrates were found 
to bind with the same affinity (Bao et al. 2003). Because of the quick production of highly 
reactive hydrogen peroxide, either the enzyme or the substrate must be immobilised in order to 
prevent spoiling. GOD has been successfully microencapsulated in liposomes which removes 
the inhibitory effect of the hydrogen peroxide and increases the stability of the enzyme 
(Yoshimoto et al. 2005; Yoshimoto et al. 2006). Liposomes are small vesicles in which an 
aqueous volume is enclosed by a membrane made of lipid molecules (Rodriguez-Nogales 
2004). This technology may also be useful for the sustained release of hydrogen peroxide as a 
preservative in food, cosmetics or toiletries (Rodriguez-Nogales 2004).  
 
GOD has also been immobilised using GA chemistry onto polypropylene films, which were 
then found to have antimicrobial activity, and may be a useful biomaterial for novel 
antimicrobial food packaging (Vartiainen et al. 2005). In this paper, the antimicrobial activity of 
the polypropylene films was tested by culturing the test solution to look for surviving colonies 
of the bacteria Bacillus subtilis and E. coli.  
 
Thermostability of enzymes is a significant problem in the production of food packaging, as the 
temperatures needed to make materials such as polypropylene films are very high and are likely 
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to denature the enzyme (Fuglsang et al. 1995). It has been stated that GOD is more likely to be 
involved in food processing than in packaging for shelf-life preservation due to the effect of 
hydrogen peroxide on the food, as it is known to cause rancidity due to lipid oxidation 
(Fuglsang et al. 1995). However, there is currently a large amount of research being undertaken 
in this area, with the opportunity to revolutionise the way consumables are preserved in the 
future. 
 
 
1.14 Conclusion 
 
The properties of both amyloid fibrils and GOD make them ideal for investigation of a new 
bionanomaterial. The ability of amyloid fibrils to be functionalised and the inherent strength of 
the fibrils make them useful for both adding enzyme function and strength to the 
bionanomaterial. GOD is extremely stable and catalyses a reaction that is useful in many areas, 
such as fermentation, blood glucose measurement and antimicrobial activity. PVOH is a useful 
material due to the environment it provides for enzyme immobilisation, and its availability. 
Thus these three constituents provide a good model for creation of a ‘proof of concept’ 
bionanomaterial based on enzyme immobilisation onto amyloid fibrils.   
 
 
1.15 Thesis outline 
 
Chapter Two describes the experimental methods used in this thesis. Chapter Three describes 
amyloid fibril formation from bovine insulin and bovine lens crystallins. Chapter Four assessed 
the attachment of GOD to amyloid fibrils using GA. Chapter Five investigated attachment of 
GOD to amyloid fibrils via the carbohydrate shell of the glycoprotein and the effect of removal 
of the glycoprotein shell on cross-linking via GA. In Chapter Six the functionalised amyloid 
fibrils were incorporated into a film system and this bionanomaterial was characterised for both 
its material and antimicrobial properties.   
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2. CHAPTER TWO – METHODS  
 
 
2.1 General materials and methods 
 
Unless otherwise stated, all chemicals were obtained from Sigma Chemical Co., BDH 
Laboratory Supplies or Invitrogen. Bovine eye lenses were supplied by a local abattoir (CMP 
Canterbury Ltd, Seafield Road, Ashburton, New Zealand). Commercial grade glucose oxidase 
from Aspergillus niger (Type X-S) was obtained from Sigma Chemical Co. 
 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis was run using a NuPAGE system 
gel electrophoresis box, with precast 10 well NuPAGE Novex® 4 – 12% Bis-Tris gradient gels 
(1.0 mm) (Invitrogen). Samples were prepared by mixing with lithium salt of dodecyl sulfate 
(LDS) 4 x sample buffer and heating at 90 °C for 5 minutes to aid the reduction of disulfide 
bonds. An Invitrogen Novex® Sharp™ Pre-stained Wide-Range Protein Standard ladder was 
also run for each gel. Electrophoresis was carried out at a constant voltage of 200 V in NuPAGE 
2-(N-morpholino)ethanesulfonic acid (MES)-SDS running buffer (50 mM MES, 50 mM Tris 
base, 0.1% SDS, 1 mM ethylenediaminetetraacetic acid (EDTA) at pH 7.4) at room temperature 
for 50 minutes. Gels were stained with Coomassie R-250 (2.5 g/l Coomassie R-250, 10% (v/v) 
glacial acetic acid, 45% (v/v) methanol and 45% (v/v) distilled water (dH2O)) for 30 minutes, 
and then destained with destaining solution (30% (v/v) methanol, 10% (v/v) acetic acid and 
60% (v/v) dH2O) for at least one hour. Gel photographs were then taken using a BioImaging 
System (Syngene). 
 
pH measurements were obtained using an UltraBasic UB10 pH meter (Denver Instrument Co.) 
(unless otherwise stated), fitted with a high-performance glass body pH/Tris electrode.  
 
Protein concentrations of unknown solutions were measured on a Thermo Scientific 
NanoDrop™ ND-1000 Spectrophotometer (A280) (Thermo Fischer Scientific), unless stated 
otherwise. Measurements of three replicates were averaged and corrected for a blank of the 
sample buffer. 
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Fluorescence and absorbance measurements were recorded by a BMG Labtech FLUOstar 
OPTIMA Platereader (Alphatech Systems Ltd.). For fluorescence measurements Nunc™ 96 flat 
well black, optical bottom plates were used, with Nunc™ 236707 sealing tape used when 
heating of samples was required. For absorbance measurements, SARSTEDT 96 flat well 
optical plates were used. 
 
All fungi were supplied by Craig Galilee, School of Biological Sciences, University of 
Canterbury. 
 
 
2.2 Amyloid fibril formation 
 
Amyloid fibrils were formed from bovine insulin and from bovine eye lens crystallins. 
Following exposure to amyloid fibril forming conditions, the samples were tested for presence 
of amyloid fibrils using a thioflavin T assay (Section 2.2.6) and transmission electron 
microscopy (TEM) (Section 2.4.8). 
 
 
2.2.1 Formation of amyloid fibrils by bovine insulin 
 
Insulin amyloid fibrils were made from adapted in-house methods (Nielsen et al. 2001). Bovine 
insulin was dissolved at a concentration of 5.8 mg/ml in incubation buffer (0.1 M NaCl, 
adjusted to pH 1.6 with 1 M HCl) and incubated at 60 °C for at least 48 hours. The presence of 
fibrils was indicated using a thioflavin T assay (Section 2.2.6).  
 
 
2.2.2 Crude crystallin extraction from bovine lenses 
 
Two crystallin extraction methods were used in this thesis. First, an in-house method was 
followed with modifications from the literature (Garvey et al. 2009). The second method was 
devised to be gentler on the protein and achieve a greater yield of amyloid fibrils. 
 
Method One 
In the initial method, bovine lenses were removed from cow eyes obtained from an abattoir and 
stored at -20 °C. Crystallin proteins were extracted from bovine lenses by homogenisation in a 
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buffer containing 50 mM Tris, pH 7.2, 1 mM dithiothreitol  (DTT) and 1 mM 
ethylenediaminetetraacetic acid (EDTA) using the Magic Bullet™ blender. The homogenate 
was centrifuged at 12,000 rpm for 30 minutes at 4 °C. The supernatant was removed and 
analysed for protein concentration using a Thermo Scientific NanoDrop™ ND-1000 
Spectrophotometer (A280) (Section 2.1). The crystallin extraction process was repeated multiple 
times with comparable protein concentrations. The extract was then filtered through a 0.22 µm 
MILLEX®GP Millipore Express® PES Membrane Filter Unit and retained as crude crystallin 
protein.  
 
Method Two 
To achieve a greater protein yield and minimise protein degradation, bovine lenses were 
removed from cow eyes obtained from an abattoir and stored at -20 °C. Crystallin proteins were 
extracted from bovine lenses by homogenisation in a buffer containing 50 mM Tris, pH 7.2, 1 
mM DTT and 1 mM EDTA, using an IKA® Ultra Turrax® Tube Disperser with Tube ST-20. 
The lenses were homogenised for 1 minute, then left on ice for 1 minute. This cycle was 
repeated until the lens had been homogenised for 30 minutes. The homogenate was then 
centrifuged for 30 minutes at 13,000 x g in an Eppendorf® MiniSpin® Plus centrifuge. The 
supernatant was removed and pooled. The protein concentration of the supernatant was then 
measured using a Thermo Scientific NanoDrop™ ND-1000 Spectrophotometer (A280) (Section 
2.1). The crystallin extraction process was carried out multiple times with comparable protein 
concentrations. The extract was then stored at 4 °C for up to two weeks.  
 
 
2.2.3 Purification of α-, β- and γ-crystallin 
 
Crude bovine lens crystallin protein samples, prepared as described above, were purified by 
size-exclusion chromatography on a HiLoad™ 16/60 Superdex™ 200 prep grade column 
(Garvey et al. 2009). The elution speed was 0.5 ml/min, with 20 mM Tris (pH 8.0) at 4 °C. The 
absorbance at 280 nm was monitored, and 0.5 ml fractions were collected. The crystallin 
purification process was carried out multiple times and achieved a typical elution profile with 
high reproducibility. Samples were run on an SDS-PAGE gel (Section 2.1) to assess purity. The 
concentration of each sample was determined using a Thermo Scientific NanoDrop™ ND-1000 
Spectrophotometer (A280) (Section 2.1).  
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2.2.4 Formation of amyloid fibrils by crude crystallin and α-, β- and γ-crystallin 
 
Amyloid fibrils were formed from crystallin proteins using adapted in-house methods (Garvey 
et al. 2009). Crude crystallin was diluted to a concentration of 5.8 mg/ml in 10% (v/v) 
trifluoroethanol (TFE) (adjusted to pH 2.0 with 1 M HCl). Bovine α-crystallin was dissolved at 
a concentration of 5.8 mg/ml in 10% (v/v) TFE (adjusted to pH 2.0 with 1 M HCl). The pH of 
the solution was tested, and further 0.1 M HCl was added dropwise until the pH of the solution 
was equal to 2.0. The solution was then incubated at 60 °C for 12 hours. This fibrillisation 
method was repeated with β- and γ-crystallin. Thioflavin T assays (Section 2.2.6) were 
performed on the samples, and the presence of fibrils was indicated using TEM (Section 2.4.8) 
(Burke and Rougvie 1972; LeVine III 1999; Whittingham et al. 2002).  
 
 
2.2.5 Pepsin digestion of bovine crystallin amyloid fibrils 
 
Pepsin was added to the crystallin amyloid fibril samples (1:100 w/w pepsin:crystallin) and 
incubated at 4 °C for one week (Zurdo et al. 2001). The digested sample was spun at 8,000 x g 
for 2 minutes and the fibril pellet re-suspended in nanopure water, previously adjusted to pH 2.0 
with HCl. The presence of fibrils was then reassessed using TEM (Section 2.4.8). The results 
were repeated three times with high reproducibility. 
 
 
2.2.6 Thioflavin T (ThT) assay 
 
The ThT assay was carried out following in-house methods. 1 mM thioflavin T was made up 
fresh in nanopure water and added to 5.8 mg/ml amyloid fibril samples in a NUNC 96 well 
microplate to achieve a final concentration of 5 µM, in a final volume of 200 µl. ThT 
fluorescence emission intensity was measured using excitation/emission filters of 450 and 485 
nm, respectively, using a BMG Labtech FLUOstar OPTIMA plate reader (LeVine III 1999) 
(Section 2.1). Fluorescence was measured for three replicates with a standard error of less than 
5% for each assay. 
 
Time-course ThT fluorescence measurements were carried out in a similar way, following in-
house methods. 1 mM thioflavin T was made up fresh in nanopure water and added to 5.8 
mg/ml protein samples in a NUNC 96 well microplate to achieve a final concentration of 5 µM, 
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2.4 Cross-linking of amyloid fibrils to GOD enzyme 
 
Following amyloid fibril formation by protein from both bovine insulin and bovine eye lens 
crystallin sources, cross-linking experiments were undertaken to attach GOD to amyloid fibrils. 
Three methods were used, glutaraldehyde cross-linking, sugar oxidation by periodate, and 
glutaraldehyde cross-linking following deglycosylation. Several experimental techniques were 
then employed to assess the degree of GOD cross-linking to amyloid fibrils. 
 
 
2.4.1 Glutaraldehyde cross-linking 
 
Glutaraldehyde (GA) concentrations of 5, 10, 15, 20, 50, 100, 150, and 200 mM were used to 
determine the best concentration for cross-linking GOD to amyloid fibrils. Each GA 
concentration was added to 2 mg/ml GOD in 50 mM phosphate buffer at pH 7.4, and nanopure 
water adjusted to pH 2.0 with HCl in a ratio of 1:1:1. Samples were then run on an SDS-PAGE 
gel (Section 2.1). The chosen GA concentration (150 mM) from the gel was used in further 
experiments.  
 
1.9 mg/ml insulin fibrils were added to an aliquot of 3% (v/v) GA to make a final concentration 
of 1% GA (150 mM), and mixed by inversion. 0.6 mg/ml GOD was then added and the samples 
were incubated for one hour at 25 °C. The pH of each cross-linked solution was tested to ensure 
a final pH of 7.0. Cross-linked samples were immediately run on an SDS-PAGE gel to assess 
degree of cross-linking (Section 2.1). This experiment was repeated with high reproducibility. 
 
 
2.4.2 Deglycosylation of GOD 
 
GOD (2 mg/ml) was incubated for 24 hours at 37 °C with 10 U α-mannosidase (E.C. 3.2.1.24) 
and 30 mU endoglycosidase H (E.C. 3.2.1.96) in 30 mM potassium phosphate buffer (pH 5) 
(Sohail Akhtar and Bhakuni 2003). The degree of deglycosylation was assessed by SDS-PAGE 
(Section 2.1).  
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2.4.3 Ninhydrin assay 
 
The ninhydrin assay was performed using in-house methods (Friedman et al. 1984). Ninhydrin 
buffer was prepared by adding lithium acetate buffer (4M lithium acetate, adjusted to pH 5.2 
with acetic acid) to ninhydrin solution (0.01 M ninhydrin, 0.01 M hydrindantin and 75% 
dimethyl sulfoxide (DMSO) to achieve a final ratio of lithium acetate buffer to ninhydrin 
solution of 1:3. The ninhydrin solution was then added to diluted protein samples, including a 
sample blank. The solution was heated at 100 °C for 10 minutes, vortexing the samples after 
five minutes. The solution was then cooled in an ice bath. 50% (v/v) ethanol was then added to 
each sample and vortexed. The absorbance of three sample replicates was read at 570 nm and 
corrected for the sample blank. 
  
 
2.4.4 Periodate oxidation of GOD 
 
GOD (2 mg/ml) was incubated for 24 hours at 4 °C with increasing molar concentrations of 
sodium periodate to mannose of 0.1:1, 0.2:1, 0.3:1, 0.5:1, 0.75:1, 1:1 and 2:1 (Section 5.3) 
(Kozulic et al. 1987). The degree of carbohydrate shell oxidation was assessed by SDS-PAGE, 
and the most effective concentration ratio of 2:1 was chosen. GOD oxidised with a molar 
concentration of sodium periodate to mannose of 2:1 was then reduced using increasing molar 
concentrations of sodium borohydride to mannose of 1:1, 10:1, 25:1, 50:1 and 100:1. The 
degree of carbohydrate shell reduction was assessed by SDS-PAGE, and the most effective 
concentration ratio of 100:1 was chosen. Sodium borohydride was then added to 2 mg/ml 
oxidised GOD and 5.8 mg/ml insulin amyloid fibrils at a molar concentration of sodium 
borohydride to mannose of 100:1 (Kozulic et al. 1987). The degree of cross-linking was then 
assessed by SDS-PAGE (Section 2.1). 
 
 
2.4.5 Preparation of sucrose gradient 
 
Cross-linked samples of GOD and fibrils as prepared above (Section 2.4.1, Section 2.4.2 and 
Section 2.4.4) were loaded onto 14 × 95 mm Ultra-Clear centrifuge tubes (Beckman) prepared 
with a step gradient formed by five layers containing 80%, 70%, 50%, 30%, and 0% sucrose, 
respectively. The tubes were centrifuged for 16 hours at 180,000 × g (33,000 rpm) at 4 °C using 
a SW40Ti rotor and a L-70 Beckman ultracentrifuge (Schrödel and De Marco 2005). The 
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centrifuge tube was then pierced using a 16 gauge needle, 1 cm from the bottom of the tube, and 
1 ml fractions were removed. These fractions were then tested for GOD activity using the 
Amplex red assay (Section 2.3), the presence of amyloid fibrils using the ThT assay (Section 
2.2.6), and for protein using the Bradford assay (Section 2.4.7). 
 
 
2.4.6 Centrifugation of cross-linked samples 
 
Cross-linked samples of GOD and fibrils as prepared in Section 2.4 were spun at 14,500 x g for 
2 minutes. The supernatant was removed and the pellet resuspended in nanopure water. This 
washing cycle was repeated for five washes. Bradford, ThT and Amplex Red assays (Sections 
2.4.7, 2.2.6, and 2.3, respectively) were then carried out on both supernatant and pellet samples. 
 
 
2.4.7 Bradford assay 
 
8 µl of cross-linked samples were added to a SARSTEDT 96 flat well optical plate and diluted 
with 152 µl nanopure water. Bradford reagent was diluted 1:4 (v/v) with water and added to 
samples to achieve a final dye concentration of 4%. Absorbance of the samples was then read at 
540 nm using a Labtech FLUOstar OPTIMA plate reader (Bradford 1976) (Section 2.1). 
Absorbance was measured for three replicates with a standard error of less than 5% for each 
assay. 
 
 
2.4.8 Transmission electron microscopy (TEM) studies 
 
Bovine insulin and bovine lens crystallin fibrils (5.8 mg/ml) were stained with 1% uranyl 
acetate on Formvar-coated copper grids (200 mesh). Samples were then washed with nanopure 
water. Grids were then viewed at 89,000 x magnification (unless otherwise stated) using a 
Morgagni 268D TEM (FEI Company, Oregon, USA), operating at 80 kV and fitted with a 40 
µm objective aperture (Burke and Rougvie 1972; Whittingham et al. 2002).  
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2.4.9 Differential scanning fluorimetry (DSF) of cross-linked samples 
 
DSF was performed on cross-linked samples of GOD and fibrils as prepared in Section 2.4 
using a BioRad IQ5 Multicolour Real-Time PCR Detection System. 10x SYPRO Orange dye 
was added to 0.5 mg/ml protein and 50 mM sodium phosphate buffer at pH 7.4 in a 96-well 
thin-wall PCR plate (Bio-Rad). The plate was sealed and heated in increments of 0.5 °C, with a 
10 second dwell time. Fluorescence changes were monitored simultaneously with a charge-
coupled device camera. The wavelengths for excitation and emission were 490 and 575 nm, 
respectively. Experiments were carried out in triplicate for each condition.  
 
 
2.4.10 Thermal denaturation of cross-linked samples 
 
Cross-linked samples were prepared as in Section 2.4. Each sample was heated at 50 °C for 5 
minutes and placed on ice. This was then repeated with fresh cross-linked samples at 60, 70, 80 
and 90 °C. GOD activity was then tested for each sample using the Amplex Red assay (Section 
2.3). Experiments were carried out in triplicate for each condition. 
 
 
2.4.11 Circular dichroism (CD) of cross-linked samples 
 
CD spectra were generated on a Jasco J-815 spectrophotometer. The CD spectra were measured 
at a GOD concentration of 0.03 mg/ml and an insulin fibril concentration of 0.11 mg/ml in a 1 
cm cell. Temperature scans were monitored at 220 nm, and data were collected at 0.5 °C 
intervals between 40 and 90 °C with a 1 second averaging time. Cuvettes were stopped to 
prevent evaporation. The values obtained were normalised by subtracting the baseline recorded 
for the sample buffer. 
 
 
2.5 Poly(vinyl alcohol) (PVOH) films 
 
PVOH films were made using Shiva Rao’s in-house method (Rao 2008). PVOH was dissolved 
in water by heating to 60 °C to a concentration of 10% (w/v). 18 ml of cross-linked sample was 
then added to 6 ml PVOH to achieve a final concentration of 2.5%. Films were mixed by 
inversion, taking care to avoid air bubbles, and poured into 10 x 7 cm gel casting trays. The 
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trays were measured with a spirit level. The films were then covered with paper and dried under 
ambient conditions for seven days, removed from the trays and stored in separate plastic bags. 
 
Films containing ThT were made using the same method, with 1 mM ThT added before mixing 
the films, to achieve a final concentration of 5 µM. Films were then cast as above. 
 
 
2.5.1 Scanning electron microscopy (SEM) 
 
Film samples were studied using the field emission scanning electron microscope (FE-SEM) 
(with assistance from Mike Flaws, Senior Technician, Department of Mechanical Engineering, 
University of Canterbury). Film samples from Section 2.5 were cut and prepared by splutter 
coating with gold and incubated at 60 °C overnight. Samples were then viewed using a 1,000 x 
objective on a JEOL JSM-7000F high resolution FE-SEM.  
 
 
2.5.2 Confocal microscopy 
 
1 x 1 cm pieces were cut from films prepared in Section 2.5 and mounted on slides using 
glycerol. Confocal optical sections of film samples were taken using a Leica Microsystems TCS 
SP5 confocal microscope with a Leica HCX PL APO 63 x 1.3 glycerol-immersion objective. 
An excitation of 405 nm and an emission detection of 430 – 520 nm were used.  
 
 
2.6 Antibacterial experiments 
 
Luria Bertani (LB) Agar (25 g/L LB and 15 g/L Select Agar) was prepared and autoclaved, 
using in-house methods. For glucose containing plates, 10 g/l glucose was added to the LB Agar 
before autoclaving. E. coli (XL1 Blue) was inoculated onto LB Agar plates. Each film sample 
was cut into circles of 1 cm diameter and two pieces of each film sample were placed on each 
plate. The plates were incubated at 37 °C for 48 hours. Three replicates of each plate were 
made, with high reproducibility. 
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2.7 Antifungal experiments 
 
Potato dextrose agar (PDA) (39 g/L PDA and 5 g/L Select Agar) was prepared and autoclaved, 
using in-house methods. Fusarium (CANU-F14), Aspergillus (CANU-M43) and Rhizopus 
(CANU-C245) were inoculated onto potato dextrose agar (PDA) plates. Each film sample was 
cut into circles of 1 cm diameter. One piece of film was placed on each plate. Fungi were 
incubated at 25 °C for one week to assess antimicrobial activity. Three replicates of each plate 
were made, with high reproducibility. 
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3. CHAPTER THREE - FORMATION OF 
AMYLOID FIBRILS FROM BOVINE 
INSULIN AND BOVINE LENS 
CRYSTALLIN 
 
 
3.1 Introduction 
 
Amyloid fibrils have potential for use in a number of industrial applications, as discussed in 
Section 1.5. The formation of insulin amyloid fibrils is well characterised, and was 
demonstrated in this chapter (Brange et al. 1997; Jiménez et al. 2002; Devlin et al. 2006). 
Crystallins are a good source of amyloid fibrils, as they are a waste material from the meat 
processing industry in New Zealand. Amyloid fibrils can be inexpensively produced from crude 
crystallin protein mixtures in significant quantity, which is important for use in commercial 
applications (Ecroyd and Carver 2008; Garvey et al. 2009). The ability to form amyloid fibrils 
from both crude and purified bovine lens crystallin proteins was assessed in this chapter. The 
method of crude crystallin extraction was modified to produce a greater protein yield and the 
properties of the resulting amyloid fibrils such as protease resistance and pH stability were then 
investigated.    
 
 
3.2 Formation of insulin amyloid fibrils 
 
Insulin amyloid fibrils were formed by subjecting bovine insulin to conditions of low pH and 
high temperature known to cause fibrillation, following literature methods (Section 2.2.1) 
(Nielsen et al. 2001). The time-course formation of amyloid fibrils was monitored using ThT. 
ThT is a fluorescent dye that elicits a distinctly different excitation and emission spectrum upon 
amyloid β-sheet binding (LeVine III 1993; LeVine III 1999). The time-course for amyloid fibril 
formation is given in Figure 3.1. 
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Figure 3.1 
Time-course formation of amyloid fibrils by bovine insulin and bovine crystallin. 0.79 mg/ml ThT was 
added to 5.8 mg/ml bovine insulin in 0.1 M NaCl, adjusted to pH 1.6 with 1 M HCl, and incubated for 
1400 minutes at 60 °C. Error bars indicate the standard error of the mean of four replicates, and are less 
than 5%. 
 
The results of the time-course incubation showed a steep increase in fluorescence for insulin 
within the first 120 minutes of incubation, consistent with literature reports (Hua and Weiss 
2004; Ahmad et al. 2005).  
 
TEM was also used for the identification and characterisation of insulin amyloid fibrils. The 
results are shown in Figure 3.2. These insulin amyloid fibrils have a straight, long, thin, 
unbranched morphology consistent with previous research, with a diameter of around 6 nm 
(Rochet and Lansbury 2000; Cherny and Gazit 2008).  
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Figure 3.3 
TEM image of insulin amyloid fibrils. Representative TEM image of 5.8 mg/ml crude crystallin in 10% 
TFE, adjusted to pH 2.0 with 1 M HCl at 60 °C for four days. An amyloid fibril is indicated with an 
arrow. Scale bar = 0.2 µm.  
 
 
 
3.4 Purification of bovine crystallin 
 
Crude bovine crystallin prepared in Section 2.2.2 (Method One) by the initial in-house method, 
was purified in order to achieve a homogenous fibril sample for use in cross-linking 
experiments. It was initially thought that the two morphologies seen in the crude sample may 
have been formed from different crystallin proteins. Thus purification was carried out in order 
to yield homogenous long, thin amyloid fibrils in a nanoscaffold formation for enzyme 
immobilisation. This separation gave a typical elution profile with six protein peaks, as shown 
in Figure 3.4. The fractions for each crystallin peak were pooled and lyophilised.  
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Figure 3.4 
Purification of crude crystallin. The α-crystallin peak corresponded to the fractions eluting between 50-
65 ml, the βH-crystallin peak corresponded to the fractions eluting between 70-80 ml, the βL-crystallin 
peak corresponded to fractions eluting between 80-90 ml, the γS-crystallin peak corresponded to the 
fractions eluting between 95-105 ml, and the γT-crystallin peak corresponded to the fractions eluting 
between 107-109 ml. 
 
This elution profile shows separation between the crystallin fractions. The first peak 
(unlabelled) is high molecular weight protein aggregate. The second peak, α, consists of the two 
closely related subunits αA and αB. The third peak (βH) is high molecular weight, or octameric, 
β-crystallin, and the fourth peak (βL) is low molecular weight dimeric and trimeric β-crystallin. 
The fifth (γS) and sixth (γT) peaks consist of γS-crystallin and total γ-crystallins, respectively. 
This result shows a similar high degree of separation to crystallin purification reported in the 
literature (Carver et al. 1996). Following lyophilisation, fractions were reconstituted in 
nanopure water at a concentration of 5.8 mg/ml and run on an SDS-PAGE gel to assess purity 
(Figure 3.5). 
 
The crude crystallin sample produced a number of bands (Lane 1). The α-crystallin sample in 
Lane 2 produced two bands, one band of ~19 kDa (Band a), and another band of 20 kDa (Band 
b). These bands are consistent with the molecular weight of the two mammalian α-crystallin 
subunits, which are ~20 kDa (Ecroyd and Carver 2008). The βH-crystallin sample produced 
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3.5 TEM of purified crystallin amyloid fibrils 
 
The α- and βH-crystallin samples (Figure 3.6A and B, respectively) show long thin amyloid 
fibrils amongst amorphous aggregate, indicated with an arrow. These amyloid fibrils are 
consistent with the morphology of insulin amyloid fibrils, with a diameter of around 6 nm 
(Rochet and Lansbury 2000; Cherny and Gazit 2008). There are no long, thin fibrillar structures 
clearly visible in either the βL-, γS- and γT-crystallin samples (Figure 3.6C, D and E, 
respectively), suggesting amorphous aggregate. This is inconsistent with previous results, which 
state that all the crystallin fractions were able to form amyloid fibrils (Garvey et al. 2009). This 
could be due to the conditions used to form amyloid fibrils, as amyloid fibrils have been found 
to have different morphologies in different conditions (Ecroyd and Carver 2008). The protein 
fractions were not dialysed following purification, and therefore contained a high concentration 
of Tris buffer, in comparison to previous methods where the purified crystallins were dialysed 
(Garvey et al. 2009). The protein fractions were also at a lower concentration than crystallin 
fractions used in previous research, which were all found to form amyloid fibrils (Meehan et al. 
2004).  
 
Further work was not done because the crude crystallin gave the best amyloid fibril formation, 
as judged by TEM. The amyloid fibrils were clearly defined and there was minimal aggregate 
present in comparison to purified samples. This confirms that amyloid fibrils can be readily 
prepared from this waste protein. Crude crystallin amyloid fibrils were therefore used for further 
experiments. To test the fibrillar nature of the short, curly structures, the crude crystallin sample 
was exposed to pepsin, a proteolytic enzyme. Before exposure to pepsin, the crude crystallin 
extraction method was modified to obtain a higher protein yield, and to reduce protein 
aggregation (Section 2.2.2 (Method Two)). This method used an Ultra Turrax™ without the 
grinding attachment, in place of the Magic Bullet, in order to gently homogenise the lenses. The 
tubes were placed on ice between homogenisation cycles to prevent aggregation. The samples 
were then centrifuged in 1.5 ml Eppendorf tubes to generate better separation between crystallin 
protein and other cellular matter. This adapted method gave a greater protein concentration than 
the previous in-house method (results not shown) and a higher proportion of long, thin amyloid 
fibrils compared to short, curly structures seen in Figure 3.3. This method of crude crystallin 
extraction and amyloid fibril formation was thus used for further experiments, including pepsin 
digestion experiments.   
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A      B 
C      D 
 
   
 
 
 
 
 
 
E  
Figure 3.6 
TEM images of purified crystallin amyloid fibrils. Representative TEM images of purified crystallin 
fractions subjected to amyloid fibril forming conditions: α-crystallin (A) βH-crystallin (B), βL-crystallin 
(C), γs-crystallin (D) and γT-crystallin (E). Amyloid fibril-like structures are indicated with an arrow. 
Scale bar = 0.2 µm.  
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Figure 3.8 
Pepsin digestion of crude crystallin amyloid fibrils. 2.9 mg/ml crystallin amyloid fibrils following 
digestion with pepsin. Scale bar = 0.2 µm. 
 
 By nature, amyloid fibrils are resistant to proteolytic digestion (Zurdo et al. 2001). The short, 
curly fibrils were no longer visible following proteolytic digestion, whereas the long, thin 
amyloid fibrils were clearly visible Figure 3.8. This indicates that the short, curly structures seen 
in the TEM images were less resistant to proteolytic digestion than the long, thin fibrils, and 
thus may not be amyloid in nature. Another test to ensure the fibrillar nature of the short, curly 
structures is exposure to high pH, which is also important when cross-linking using 
glutaraldehyde, which requires an increase in pH for optimum reaction. 
 
 
3.7 pH studies 
 
Optimal cross-linking by glutaraldehyde occurs in basic conditions, where the amino groups of 
the protein are unprotonated, making the reaction of glutaraldehyde with free amino groups 
favourable (Wine et al. 2007). In contrast, the methods employed in this thesis involve the 
formation of both insulin and crystallin amyloid fibrils in acidic conditions (Section 2.2). In 
order to cross-link amyloid fibrils using glutaraldehyde effectively, the pH of the solution has to 
be increased. Insulin amyloid fibrils are known to be stable at pH extremes (Gras 2007); 
however, previous research has shown that when exposed to neutral pH, amyloid fibrils retain 
ThT binding ability but display different morphologies when visualised using TEM (Rao 2008).  
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A       B 
C       D 
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Figure 3.9 
Effect of pH change on crude crystallin amyloid fibril morphology. 0.1 M sodium hydroxide was added 
to pre-fibrillised 5.8 mg/ml crude crystallin amyloid fibril samples to give increasing pH conditions; pH 2 
(A), pH 3 (B), pH 4 (C), pH 5 (D) and pH 7 (E). Scale bar = 0.2 µm. 
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Less is known about the pH stability of crystallin amyloid fibrils. Therefore, the effect of 
increasing pH on the morphology of pre-formed crystallin amyloid fibrils was assessed by 
adding sodium hydroxide before cross-linking experiments using glutaraldehyde were carried 
out (Figure 3.9).  
 
The crude crystallin sample given in (Figure 3.9A) shows the long, thin fibrillar structures 
characteristic of amyloid fibrils. When the pH of the pre-formed fibrils is increased using 
NaOH, the definition of the amyloid fibrils becomes increasingly poor (Figure 3.9B – E). The 
increased clumping with increasing pH indicates that either the crude crystallin amyloid fibrils 
are affected by increase in pH, or that unfibrillised protein present in the heterogeneous crude 
sample is prone to aggregation upon increase of pH conditions. However, this effect could also 
be due to the increase of salt upon addition of NaOH. It has previously been stated that 
excessive salt in samples can obscure the identification of amyloid fibrils (Nilsson 2004). As 
mentioned in Section 2.4.8, samples were washed following staining to reduce the amount of 
salt on the TEM grids in order to reduce the amount of salt present in the sample. Despite this, 
the pH studies provide useful information for the use of crystallin amyloid fibrils for further 
applications (Chapter Six). 
 
 
3.8 Conclusions 
 
The ability to form amyloid fibrils from crude bovine lens crystallin protein was demonstrated 
in this chapter. Size exclusion chromatography was an effective method for purification of 
crude crystallin samples. The crude, α- and βH-crystallin preparations formed amyloid fibrils, as 
determined by TEM. Short, curly structures that were also present were not resistant to 
proteolytic digestion or increase in pH, so were unlikely to be fibrillar. Development of the 
crude crystallin extraction method yielded a higher protein concentration and amyloid fibril 
samples containing a higher proportion of long, straight amyloid fibrils. The crude crystallin 
method was faster than the purification method and produced a more useful enzyme scaffold, so 
crude crystallins were used in further experiments to demonstrate the ability to functionalise a 
crude amyloid fibril scaffold system. 
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4. CHAPTER FOUR - CROSS-LINKING 
GLUCOSE OXIDASE TO AMYLOID 
FIBRILS  
 
 
4.1 Introduction 
 
In this chapter, the attachment of GOD to amyloid fibrils using GA is explored. Cross-linking 
GOD to amyloid fibrils has potential to impart stability to the enzyme and functionality to the 
amyloid fibrils, as discussed in Sections 1.10 and 1.11. There is also evidence to suggest that 
immobilisation of GOD stabilises the active conformation of the enzyme (Tiller et al. 2002). 
Enzyme assays, thermal denaturation techniques and CD spectroscopy were employed in this 
chapter to assess the effect of attachment on GOD stability.  
 
The effect of enzyme immobilisation on the integrity of amyloid fibrils must also be assessed, to 
test the theory that amyloid fibrils can be functionalised via the side chains of their constituent 
amino acids. To investigate the impact of cross-linking of GOD to amyloid fibrils on enzyme 
activity, any material that had not been cross-linked was separated from the cross-linked 
amyloid enzyme scaffold. Ideally, the best way to separate amyloid fibrils from cross-linked 
amyloid fibrils would be using protein separation techniques based on molecular weight. 
However, because amyloid fibrils have a very large molecular weight, they are difficult to 
separate via conventional biochemical separation techniques. The most effective techniques for 
separating large crude mixtures are gel electrophoresis and centrifugation. Thus, in this chapter, 
several centrifugation and electrophoretic techniques were investigated in order to separate 
cross-linked material. The samples were then viewed microscopically using TEM to visually 
assess cross-linked amyloid fibril morphology.  
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SDS-PAGE separates proteins based on molecular weight. In Figure 4.1, the gel shows a band 
from 70-80 kDa, which corresponds to the molecular weight of the GOD monomer in all sample 
lanes. There is also a band around 160 kDa, which increases in intensity with increase in GA 
concentration in all cross-linked samples. This band corresponds to the molecular weight of the 
GOD dimer. This band is very faint in the sample that does not contain GA, suggesting that 
most of the GOD dimers have been denatured to monomers. In the cross-linked samples, the 
intensity of this band increases with GA concentration, indicating that increasing amounts of 
GOD dimer have been stabilised by intramolecular cross-links. There is also a faint band 
(labelled with an arrow) with a molecular weight of around 240 kDa at higher concentrations, 
which is consistent with the molecular weight of a GOD trimer. This suggests that there is also 
intermolecular GOD cross-linking at high concentrations of GA. 150 mM (1% v/v) GA was 
used in further cross-linking experiments, as it was the lowest concentration where both inter- 
and intramolecular cross-linking is observed.  
 
 
4.3 Electrophoretic studies 
 
SDS-PAGE denatures proteins using the detergent SDS and separates based on molecular 
weight. Amyloid fibrils are too large to enter the PAGE gel, and remain in the well at the top of 
the gel. GOD that has been cross-linked to the amyloid fibrils also remains in the well, attached 
to the amyloid fibrils. GOD that has not been cross-linked is free to move through the gel. The 
Experion™ capillary electrophoresis system works in a similar way to an SDS-PAGE gel, 
where denatured samples are run on a chip gel filtration column, and a gel photo is simulated 
from the resulting data (Minucci et al. 2008). 
 
 
4.3.1 Gel electrophoresis 
 
Experiments were optimised to limit intramolecular GOD cross-linking, with the addition of GA 
to amyloid fibrils first and enzyme added last, to ensure the pH of the solution was 7.4 from the 
phosphate buffer in the enzyme solution. Insulin amyloid fibril cross-linked samples and 
associated controls were run on an SDS-PAGE gel to assess the degree of cross-linking by GA. 
The results of this gel are shown in Figure 4.2. Native GOD resulted in two bands on an SDS-
PAGE gel, at 80 kDa and between 110 and 160 kDa, corresponding to the molecular weight of 
the monomer and dimer, respectively. On a denaturing gel, only the monomer was expected, 
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This gel was consistent with the cross-linking observed in the SDS-PAGE gel of GOD cross-
linking to insulin fibrils using GA in Figure 4.2. These results indicate that intermolecular cross-
links were present in the GOD molecules when reacted with GA, and that some GOD was also 
being retained in the wells of the gel with the amyloid fibrils in the cross-linked sample, 
suggesting successful attachment.  
 
 
4.3.2 Capillary electrophoresis 
A 
B 
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C 
Figure 4.4 
Experion™ capillary electrophoresis of GOD cross-linked to insulin and crystallin amyloid fibrils 
using glutaraldehyde. Data are represented as chromatograms in (A) and (B) and as a simulated gel in 
(C). A: Ladder (black), 0.6 mg/ml GOD (red), 0.6 mg/ml GOD and 1% GA (green), 1.9 mg/ml insulin 
amyloid fibrils (dark blue), 1.9 mg/ml insulin amyloid fibrils and 1% GA (light blue), 0.6 mg/ml GOD and 
1.9 mg/ml insulin amyloid fibrils (pink), and 0.6 mg/ml GOD and 1.9 mg/ml insulin amyloid fibrils and 
1% GA (yellow). B: Ladder (black), 0.6 mg/ml GOD (red), 0.6 mg/ml GOD and 1% GA (green), 1.9 
mg/ml crystallin amyloid fibrils (dark blue), 1.9 mg/ml crystallin amyloid fibrils and 1% GA (light blue), 
0.6 mg/ml GOD and 1.9 mg/ml crystallin amyloid fibrils (pink), and 0.6 mg/ml GOD and 1.9 mg/ml 
crystallin amyloid fibrils and 1% GA (yellow). C: Lane L is the ladder produced by the protein molecular 
weight standards. Lane 1 contains 0.6 mg/ml GOD (pH 7.4). Lane 2 contains 0.6 mg/ml GOD and 1% 
GA. Lane 3 contains 1.9 mg/ml insulin fibrils. Lane 4 contains 1.9 mg/ml insulin fibrils and 1% GA. Lane 
5 contains 1.9 mg/ml insulin fibrils and 0.6 mg/ml GOD. Lane 6 contains 1.9 mg/ml insulin fibrils and 0.6 
mg/ml GOD and 1% GA. Lane 7 contains 1.9 mg/ml crystallin fibrils. Lane 8 contains 1.9 mg/ml 
crystallin fibrils and 1% GA. Lane 9 contains 1.9 mg/ml crystallin fibrils and 0.6 mg/ml GOD. Lane 10 
contains 1.9 mg/ml crystallin fibrils and 0.6 mg/ml GOD and 1% GA. 
 
The chromatograms (Figure 4.4A and B) of the Experion™ data for cross-linked samples were 
used to generate a simulated gel photo (Figure 4.4C). The chromatogram for insulin amyloid 
fibril cross-linked samples (Figure 4.4A) showed a large peak at about 40 seconds in the GOD 
and GOD and insulin amyloid fibrils samples (red, pink), and a small peak at about 45 seconds; 
however, this peak was very small and hard to visualise in the simulated gel photo. Bands 
between 1.2 and 8 kDa are system peaks. Other peaks in the samples (excluding the peaks of the 
protein standards ladder (black)) were likely to be noise spikes. The chromatogram of the 
crystallin amyloid fibril cross-linked samples (Figure 4.4B) was very similar to the insulin 
amyloid fibril cross-linked samples, where there was a large peak at about 40 seconds 
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corresponding to the peak produced by the GOD sample in the GOD and crystallin amyloid 
fibril samples (red, pink). 
 
The gel photo in Figure 4.4C showed a large band in the GOD, GOD and insulin amyloid fibrils 
and GOD and crystallin amyloid fibrils lanes (Lane 1, 5 and 9). This band had a molecular 
weight of between 80 and 120 kDa, consistent with the molecular weight of different 
glycoforms of the GOD monomer (Kalisz et al. 1991). This molecular weight result indicates 
that the sample was completely denatured, compared with the SDS-PAGE gels. There was a 
faint band in the GOD and GA sample that has a molecular weight of around 160 kDa (Lane 2). 
This corresponds to the weight of the GOD dimer, suggesting a small amount of intramolecular 
cross-links between GOD molecules that were resistant to denaturation. There were no bands in 
the insulin amyloid fibrils, GOD and GA lane (Lane 6), suggesting that the enzyme was retained 
with the amyloid fibrils, which have a large molecular weight and cannot enter the capillary. 
There were some low molecular weight bands in the crystallin amyloid fibrils and crystallin 
amyloid fibrils and GOD lanes, which are likely to be unfibrillised crystallin (Lane 7 and 9). 
These bands were not present in the crystallin amyloid fibrils and GA and crystallin amyloid 
fibrils, GOD and GA samples (Lane 8 and 10), indicating that they have been cross-linked, and 
were restricted from entering the gel with the amyloid fibrils. These results are consistent with 
the SDS-PAGE gels, although they indicate a higher degree association of GOD with the 
amyloid fibrils, as the GOD band is no longer visible upon addition of amyloid fibrils and GA, 
in comparison with SDS-PAGE, where a diminished GOD band is visible. This is consistent 
with SDS-PAGE being more effective at separating non-covalently associated GOD from 
amyloid fibrils than the Experion™. Further experiments in this chapter were designed to assess 
the degree of non-covalent GOD attachment to both insulin and crystallin amyloid fibrils. 
However, the activity of the cross-linked samples was first assessed to ensure that the cross-
linked GOD was still functional. 
 
 
4.4 Activity of cross-linked samples 
 
The activity of cross-linked GOD was assessed using the Amplex Red assay, as discussed in 
Section 2.3 (Zhou et al. 1997). In this experiment, the presence of amyloid fibrils was measured 
using the ThT assay and overall protein concentration of the sample was also measured using 
the Bradford assay (Bradford 1976; LeVine III 1999). The results of the three assays are shown 
graphically in Figure 4.5. 
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Figure 4.5 
Amplex Red, thioflavin T and Bradford assays of GOD cross-linked to insulin and crystallin amyloid 
fibrils. Cross-linked samples and controls: 0.6 mg/ml GOD (1), 0.6 mg/ml GOD and 1% GA (2), 1.9 
mg/ml insulin amyloid fibrils (3), 1.9 mg/ml insulin amyloid fibrils and 1% GA (4), 0.6 mg/ml GOD and 
1.9 mg/ml insulin amyloid fibrils (5), 0.6 mg/ml GOD, 1.9 mg/ml insulin amyloid fibrils and 1% GA 
(6),1.9 mg/ml crystallin amyloid fibrils (7), 1.9 mg/ml crystallin amyloid fibrils and 1% GA (8), 0.6 mg/ml 
GOD and 1.9 mg/ml crystallin amyloid fibrils (9) and 0.6 mg/ml GOD, 1.9 mg/ml crystallin amyloid 
fibrils and 1% GA (10). Thioflavin T and Amplex Red assay fluorescence readings (clear bars and grey 
bars, respectively) are plotted on the left axis and Bradford assay absorbance readings (dark diamonds) 
are plotted on the right axis. Error bars shown are standard error of three replicates and are less than 
5%.  
 
GOD activity remained relatively unchanged upon addition of GA (Column 1 and 2), despite 
evidence of intramolecular cross-linking given in the SDS-PAGE and Experion™ experiments. 
This suggests that there is little conformational change at the active site of the enzyme during 
catalysis, which is consistent with previous reports, where GOD is described as a 
conformationally rigid protein (Wilson and Turner 1992). If there is little conformational 
change, the enzyme is unlikely to be affected by the presence of intramolecular cross-links, 
which can restrict conformational change in the enzyme (Kalisz et al. 1991). This result is 
consistent with previous research where GOD is shown to retain activity upon immobilisation 
(Tiller et al. 2002). GOD activity was also unchanged in the presence of crystallin amyloid 
fibrils, but decreased slightly in the presence of insulin amyloid fibrils (Column 6 and 10). This 
may indicate a slight loss of GOD activity upon addition of insulin amyloid fibrils. Possible 
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reasons for loss of activity could be less accessibility to substrate or product inhibition, due to 
the formation of a large amyloid fibril enzyme scaffold. GOD has previously been shown to be 
competitively inhibited by hydrogen peroxide, one of the products of the GOD-catalysed 
reaction (Bao et al. 2003). If hydrogen peroxide is unable to be released into solution due to an 
entrapment effect by the amyloid fibril scaffold, then increased inhibition would occur. 
Alternatively, this scaffold could restrict GOD access to glucose, the substrate of the enzyme 
needed for catalysis. This decrease in activity could be due to the formation of a tighter amyloid 
fibril scaffold by insulin, in comparison to that of crystallin, where a decrease was not observed. 
This can be seen in the TEM images of the scaffolds in Section 3.2 (Figure 3.2) and Section 3.3 
(Figure 3.3). This would restrict the movement of small molecules such as glucose and 
hydrogen peroxide; however, further experiments would be required to investigate the cause of 
this effect.  
 
Insulin amyloid fibrils gave a characteristic fluorescence reading in the presence of ThT 
(Column 3). The fluorescence of ThT upon binding to amyloid fibrils was decreased in the 
presence of GA (Column 4). This could be due to decreased ThT access to intercalate with 
insulin amyloid fibrils when cross-linked into a fibril scaffold. However, the fluorescence 
decrease seen in the insulin fibril samples upon addition of GA was not mirrored in the results 
of crystallin amyloid fibrils. Crystallin amyloid fibrils show increased fluorescence upon 
addition of GA (Column 7 and 8). GA has been shown to enhance fluorescence of proteins by 
production of an auto-fluorescent reaction product, characterised by a broad emission spectrum 
from around 475 to 700 nm, and has previously been used to induce auto-fluorescence in 
microscopy studies (Fester et al. 2008). This fluorescence would be detected at the filter 
wavelengths detected by the platereader (450 – 485 nm), and is thus a likely explanation for the 
increase in fluorescence seen in crystallin amyloid fibril samples, and also for the slight increase 
in fluorescence given by cross-linked GOD compared to free GOD (Column 2). 
 
The protein concentration as determined by the Bradford assay decreased slightly upon addition 
of GA in the samples containing insulin amyloid fibrils (Column 3 and 4). This was due to the 
binding mechanism of the Bradford reagent to free amino groups on proteins (Bradford 1976). 
If these free amino groups have already been reacted with GA, then the Bradford reagent can no 
longer bind, producing a lower absorbance reading. This is not the case with crystallin fibrils 
however, which may indicate a lower level of insulin amyloid fibril cross-linking by GA, and 
with GOD, which may reflect the low number of available lysine residues for cross-linking or 
only a small amount of intermolecular cross-linking (Column 7 and 8).  
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4.5 Centrifugation studies 
 
Amyloid fibrils have a large molecular weight, which causes formation of a pellet when 
centrifuged. This is useful as it allows the separation of amyloid fibrils from solution using 
centrifugation. Thus, free GOD can be separated from GOD cross-linked to amyloid fibrils, or 
non-covalently associated to amyloid fibrils, by centrifuging the sample. The experiments in 
this section investigate the use of centrifugation as an effective technique for separating free 
enzyme from cross-linked samples. In all cases, a relative measure of GOD activity, ThT 
fluorescence and protein concentration was required to compare individual fractions in a single 
experiment to locate the GOD activity. In the following figures, the scales are adjusted to 
emphasise this, and comparisons between figures cannot be directly made. 
 
Free GOD gives a characteristic centrifugation profile (Figure 4.6), allowing the effect of cross-
linking to be assessed. In the Amplex Red assay of the centrifugation samples for free GOD, 
there is a large amount of fluorescence produced in the supernatant of wash one. There is very 
little activity in any of the other remaining pellet and wash samples. In the ThT assay, there is 
no significant fluorescence in any of the samples. In the Bradford assay, there is a high 
absorbance in the pellet of the supernatant of wash one, correlating with the Amplex Red 
activity seen in this sample. There is no significant absorbance in any of the other remaining 
pellet and wash samples. GOD does not form a pellet during centrifugation at 8,000 rpm, and 
nearly all GOD is removed in the supernatant of the first wash.  
 
The centrifugation profile for GOD and GA is shown in Figure 4.7. In the Amplex Red assay, 
there is a large fluorescence reading in the supernatant sample of the first wash. There is also a 
large absorbance reading for this sample in the Bradford assay. In the ThT assay, there is no 
significant fluorescence observed for any of the samples. This result is extremely similar to the 
profile of GOD alone, suggesting that the addition of GA does not affect the centrifugation 
profile of GOD or interfere with the fluorescence reading of the Amplex Red reagent. However, 
this result differs to the result seen for GOD and GA in Figure 4.5 (Column 2). Both 
experiments were repeated with high reproducibility. The difference seen between the two 
preparations may be due to the age of GA, as GA is known to polymerise in a process involving 
aldol condensation (Wine et al. 2007). This polymerization may affect the production of the 
auto-fluorescent reaction product. 
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Figure 4.6  
Centrifugation profile of GOD. Thioflavin T and Amplex Red assay fluorescence readings (clear bars 
and grey bars, respectively) are plotted on the left axis and Bradford assay absorbance readings (dark 
diamonds) are plotted on the right axis. Samples are: wash one supernatant (1),  wash one pellet (2), 
wash two supernatant (3), wash two pellet (4), wash three supernatant (5), wash three pellet (6), wash 
four supernatant (7), wash four pellet (8), wash five supernatant (9), wash five pellet (10). Error bars 
indicate the standard error of the mean of three replicates and are less than 5%. 
Figure 4.7 
Centrifugation profile of GOD and GA. Thioflavin T and Amplex Red assay fluorescence readings (clear 
bars and grey bars, respectively) are plotted on the left axis and Bradford assay absorbance readings 
(dark diamonds) are plotted on the right axis. Samples are: wash one supernatant (1),  wash one pellet 
(2), wash two supernatant (3), wash two pellet (4), wash three supernatant (5), wash three pellet (6), 
wash four supernatant (7), wash four pellet (8), wash five supernatant (9), wash five pellet (10). Error 
bars indicate the standard error of the mean of three replicates and are less than 5%. 
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Figure 4.8 
Centrifugation profile of insulin amyloid fibrils. Thioflavin T and Amplex Red assay fluorescence 
readings (clear bars and grey bars, respectively) are plotted on the left axis and Bradford assay 
absorbance readings (dark diamonds) are plotted on the right axis. Samples are: wash one supernatant 
(1),  wash one pellet (2), wash two supernatant (3), wash two pellet (4), wash three supernatant (5), wash 
three pellet (6), wash four supernatant (7), wash four pellet (8), wash five supernatant (9), wash five 
pellet (10). Error bars indicate the standard error of the mean of three replicates and are less than 5%. 
 
Figure 4.9 
Centrifugation profile of insulin amyloid fibrils and GA. Sample contains 1.9 mg/ml insulin amyloid 
fibrils, 1% GA, and 16 mM sodium phosphate, pH 7.4. Thioflavin T and Amplex Red assay fluorescence 
readings (clear bars and grey bars, respectively) are plotted on the left axis and Bradford assay 
absorbance readings (dark diamonds) are plotted on the right axis. Samples are: wash one supernatant 
(1),  wash one pellet (2), wash two supernatant (3), wash two pellet (4), wash three supernatant (5), wash 
three pellet (6), wash four supernatant (7), wash four pellet (8), wash five supernatant (9), wash five 
pellet (10). Error bars indicate the standard error of the mean of three replicates and are less than 5%. 
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There is a large amount of ThT fluorescence observed in all of the pellet samples and none of 
the wash samples of the insulin amyloid fibril centrifugation profile (Figure 4.8). These results 
show that amyloid fibrils form a pellet during centrifugation, and that the fibrils are retained 
through successive washes. There is no Amplex Red fluorescence observed in any of the 
samples, confirming that the presence of amyloid fibrils does not interfere with the Amplex Red 
reagent. The Bradford assay results are very similar to the results of the ThT assay, where there 
is a large protein concentration in the pellet and negligible protein in the supernatant.  
 
Upon addition of GA ( Figure 4.9), there is a large amount of fluorescence in the ThT assay in 
all of the pellet samples but none of the supernatant samples, like the centrifugation profile for 
amyloid fibrils alone. The fluorescence readings are lower than in the insulin amyloid fibril only 
profile, which is consistent with previous results in Figure 4.5, where the addition of GA lowers 
the fluorescence readings of the ThT assay. The results of the Bradford assay follow the same 
trend as the ThT assay and the Bradford assay from the insulin fibrils only profile in Figure 4.8; 
however, the absorbance values are much lower. This is due to the cross-linking of free amines 
from lysine residues by GA, resulting in limited binding by the Bradford reagent as discussed in 
Section 4.4. 
 
In the Amplex Red assay in Figure 4.10, there is significant fluorescence in the supernatant of 
the first wash, and in all of the pellet samples. This indicates that some GOD is lost from the 
fibril pellet in the first wash, but not from the following washes. The remaining GOD is 
associated with the fibril pellet, suggesting there is significant non-covalent association 
occurring between GOD and the amyloid fibrils.  
 
In Figure 4.11, the centrifugation profile for GOD, insulin amyloid fibrils and GA was very 
similar to the profile for GOD and insulin amyloid fibrils alone. In the Amplex Red assay, there 
was significant fluorescence in the supernatant of the first wash, and in all of the pellet samples. 
This indicates that some GOD was lost from the fibril pellet in the first wash, but not from the 
following washes. This implies that there is non-covalent association occurring between GOD 
and insulin amyloid fibrils. However, the absorbance readings for the Bradford assay were 
much lower upon addition of GA, suggesting that there is cross-linking occurring.  
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Figure 4.10 
Centrifugation profile of GOD and insulin amyloid fibrils. Sample contains 1.9 mg/ml insulin amyloid 
fibrils and 0.6 mg/ml GOD in 16 mM sodium phosphate, pH 7.4. Thioflavin T and Amplex Red assay 
fluorescence readings (clear bars and grey bars, respectively) are plotted on the left axis and Bradford 
assay absorbance readings (dark diamonds) are plotted on the right axis. Error bars indicate the 
standard error of the mean of three replicates and are less than 5%. 
 
Figure 4.11 
Centrifugation profile of GOD and insulin amyloid fibrils and GA. Sample contains 1.9 mg/ml insulin 
amyloid fibrils, 0.6 mg/ml GOD in 16 mM sodium phosphate, pH 7.4, and 1% GA. Thioflavin T and 
Amplex Red assay fluorescence readings (clear bars and grey bars, respectively) are plotted on the left 
axis and Bradford assay absorbance readings (dark diamonds) are plotted on the right axis. Samples are 
as follows: wash one supernatant (1),  wash one pellet (2), wash two supernatant (3), wash two pellet (4), 
wash three supernatant (5), wash three pellet (6), wash four supernatant (7), wash four pellet (8), wash 
five supernatant (9), wash five pellet (10). Error bars indicate the standard error of the mean of three 
replicates and are less than 5%. 
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Crystallin amyloid fibrils displayed different characteristics to insulin amyloid fibrils; 
specifically, crystallins took longer to fibrillise and the resulting fibrils displayed different 
morphologies and showed greater sensitivity to pH (Section 3.6, Figure 3.7). This is reflected in 
the centrifugation profile of crystallin amyloid fibrils in Figure 4.12. Amyloid fibrils from both 
protein sources do not interfere with the Amplex Red assay, as there is no fluorescence seen in 
any of the samples for this assay. They both also formed a pellet and are not lost during 
consecutive washes, as shown by fluorescence in the ThT assay. In the Bradford assay, 
however, there is a significant absorbance reading in the supernatant of the first wash. This is 
likely to be washing unfibrillised protein from the pellet to the supernatant, as the crystallin 
sample is a crude preparation, consisting of several proteins. The large difference in ThT 
fluorescence between pellet samples is caused by heterogeneity of resuspended samples. 
 
The centrifugation profile for crystallin amyloid fibrils and GA (Figure 4.13) is similar to the 
centrifugation profile for crystallin amyloid fibrils alone (Figure 4.12). Unfibrillised protein is 
still removed from the sample in the supernatant of the first wash, suggesting that there is little 
cross-linking between crystallin amyloid fibrils and unfibrillised protein. This is inconsistent 
with the SDS-PAGE gel of crystallin cross-linking in Figure 4.3. Taken together, the results 
suggest that some of the unfibrillised crystallin is remaining cross-linked in the fibril pellet, and 
some unfibrillised crystallin is not cross-linked.  
 
The centrifugation profile for GOD and crystallin amyloid fibrils is shown in Figure 4.14. 
Compared with the centrifugation profile of GOD and insulin amyloid fibrils (Figure 4.10), 
there is less GOD retained in the crystallin amyloid fibril pellet. This indicates that there is less 
non-covalent association between crystallin amyloid fibrils and GOD than between insulin 
amyloid fibrils and GOD. 
 
The centrifugation profile for GOD and crystallin amyloid fibrils and GA is given in Figure 
4.15. In the Amplex Red assay, there is little fluorescence after the second wash (Sample 4). 
This suggests that there is less cross-linking occurring between GOD and crystallin amyloid 
fibrils than there is between insulin amyloid fibrils and GOD; however, evidence from other 
experiments carried out in this chapter indicates that cross-linking is occurring. This is likely to 
be due to differences in separation methods.  
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Figure 4.12 
Centrifugation profile of crystallin amyloid fibrils. Sample contains 1.9 mg/ml crystallin amyloid fibrils 
and 16 mM sodium phosphate, pH 7.4. Thioflavin T and Amplex Red assay fluorescence readings (clear 
bars and grey bars, respectively) are plotted on the left axis and Bradford assay absorbance readings 
(dark diamonds) are plotted on the right axis. Samples are as follows: wash one supernatant (1),  wash 
one pellet (2), wash two supernatant (3), wash two pellet (4), wash three supernatant (5), wash three 
pellet (6), wash four supernatant (7), wash four pellet (8), wash five supernatant (9), wash five pellet (10). 
Error bars indicate the standard error of the mean of three replicates and are less than 5%. 
 
Figure 4.13 
Centrifugation profile of crystallin amyloid fibrils and GA. Sample contains 1.9 mg/ml crystallin 
amyloid fibrils and 1% GA in 16 mM sodium phosphate, pH 7.4. Thioflavin T and Amplex Red assay 
fluorescence readings (clear bars and grey bars, respectively) are plotted on the left axis and Bradford 
assay absorbance readings (dark diamonds) are plotted on the right axis. Samples are as follows: wash 
one supernatant (1),  wash one pellet (2), wash two supernatant (3), wash two pellet (4), wash three 
supernatant (5), wash three pellet (6), wash four supernatant (7), wash four pellet (8), wash five 
supernatant (9), wash five pellet (10). Error bars indicate the standard error of the mean of three 
replicates and are less than 5%. 
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Figure 4.14 
Centrifugation profile of GOD and crystallin amyloid fibrils. Sample contains 1.9 mg/ml crystallin 
amyloid fibrils and 0.6 mg/ml GOD in 16 mM sodium phosphate, pH 7.4. Thioflavin T and Amplex Red 
assay fluorescence readings (clear bars and grey bars, respectively) are plotted on the left axis and 
Bradford assay absorbance readings (dark diamonds) are plotted on the right axis. Samples are as 
follows: wash one supernatant (1),  wash one pellet (2), wash two supernatant (3), wash two pellet (4), 
wash three supernatant (5), wash three pellet (6), wash four supernatant (7), wash four pellet (8), wash 
five supernatant (9), wash five pellet (10). Error bars indicate the standard error of the mean of three 
replicates and are less than 5%. 
 
Figure 4.15 
Centrifugation profile of GOD, crystallin amyloid fibrils and GA. Sample contains 1.9 mg/ml crystallin 
amyloid fibrils, 1% GA and 0.6 mg/ml GOD in 16 mM sodium phosphate, pH 7.4. Thioflavin T and 
Amplex Red assay fluorescence readings (clear bars and grey bars, respectively) are plotted on the left 
axis and Bradford assay absorbance readings (dark diamonds) are plotted on the right axis. Samples are 
as follows: wash one supernatant (1),  wash one pellet (2), wash two supernatant (3), wash two pellet (4), 
wash three supernatant (5), wash three pellet (6), wash four supernatant (7), wash four pellet (8), wash 
five supernatant (9), wash five pellet (10). Error bars indicate the standard error of the mean of three 
replicates and are less than 5%. 
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4.6 Sucrose gradient studies 
 
Sucrose gradients provide the ability to separate proteins due to different viscosities and 
densities of the sucrose, as a protein molecule will sediment through the gradient until the 
density of the particle matches that of the sucrose (Hirst and Cox 1976). Thus a sucrose gradient 
was used to separate free GOD from immobilised GOD due to differences in density. The 
sucrose gradient method was developed from an established method for separation of aggregate 
subclasses of GFP-GST fusion protein (Schrödel and De Marco 2005). The same sucrose 
densities and centrifugation parameters were used for separating amyloid fibrils, due to the large 
molecular weight of the ordered aggregate (Chapter One, Figure 1.1) (Chiti and Dobson 2006). 
Each of the samples prepared for the centrifugation experiments were also analysed by 
centrifugation through a sucrose gradient. Fractions from the gradient were then tested for GOD 
activity using the Amplex Red assay, the presence of amyloid fibrils using the ThT assay, and 
protein concentration using the Bradford assay. The density of GOD was considerably less than 
the density of amyloid fibrils, affording efficient separation.  
 
The sucrose gradient results for free GOD are shown in Figure 4.16. In the Amplex Red assay, 
there was a large amount of fluorescence seen in the mid-range densities of the sucrose gradient 
(Fractions 4 and 5). This was mirrored in the results of the Bradford assay. There was no GOD 
activity seen in the fraction with the highest density of sucrose (Fraction 9), suggesting that 
there was little contamination between fractions. The low fluorescence observed in all fractions 
in the ThT assay indicates that sucrose does not interact with ThT. 
 
Similar results were obtained for the sucrose gradient of GOD and GA (Figure 4.17). This was 
in agreement with the centrifugation profile of GOD and GA in Figure 7. There was a slight 
increase in ThT fluorescence in the fraction with the highest sucrose density; however, this was 
seen previously in another GOD and GA result (Figure 4.5), and is likely to be auto-fluorescent 
products of the GA reaction, which are visible at the wavelengths used to record ThT 
fluorescence, as described in Section 4.4. 
 
The sucrose gradient results for insulin amyloid fibrils are given in Figure 4.18. There was a 
large amount of ThT fluorescence in the fraction with the highest sucrose density. The results of 
the Bradford assay also showed a high protein concentration in this fraction. There was no 
significant fluorescence seen in any of the fractions in the Amplex Red assay. This result was 
unchanged upon addition of GA, as shown in Figure 4.19. 
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Figure 4.16 
Sucrose gradient of GOD. Sample contains 0.6 mg/ml GOD in 16 mM sodium phosphate, pH 7.4. 
Thioflavin T and Amplex Red assay fluorescence readings (clear bars and grey bars, respectively) are 
plotted on the left axis and Bradford assay absorbance readings (dark diamonds) are plotted on the right 
axis. The first fraction contains the lowest density of sucrose (0% before centrifugation) and the last 
fraction contains the highest density of sucrose (80% before centrifugation). Error bars indicate the 
standard error of the mean of three replicates and are less than 5%. 
 
Figure 4.17 
Sucrose gradient of GOD and GA. Sample contains 0.6 mg/ml GOD in 16 mM sodium phosphate, pH 7.4 
and 1% GA. Thioflavin T and Amplex Red assay fluorescence readings (clear bars and grey bars, 
respectively) are plotted on the left axis and Bradford assay absorbance readings (dark diamonds) are 
plotted on the right axis. The first fraction contains the lowest density of sucrose (0% before 
centrifugation) and the last fraction contains the highest density of sucrose (80% before centrifugation). 
Error bars indicate the standard error of the mean of three replicates and are less than 5%. 
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Figure 4.18 
Sucrose gradient of insulin amyloid fibrils. Sample contains 1.9 mg/ml insulin amyloid fibrils in 16 mM 
sodium phosphate, pH 7.4. Thioflavin T and Amplex Red assay fluorescence readings (clear bars and 
grey bars, respectively) are plotted on the left axis and Bradford assay absorbance readings (dark 
diamonds) are plotted on the right axis. The first fraction contains the lowest density of sucrose (0% 
before centrifugation) and the last fraction contains the highest density of sucrose (80% before 
centrifugation). Error bars indicate the standard error of the mean of three replicates and are less than 
5%. 
 
Figure 4.19 
Sucrose gradient of insulin amyloid fibrils and GA. Sample contains 1.9 mg/ml insulin amyloid fibrils in 
16 mM sodium phosphate, pH 7.4 and 1% GA. Thioflavin T and Amplex Red assay fluorescence readings 
(clear bars and grey bars, respectively) are plotted on the left axis and Bradford assay absorbance 
readings (dark diamonds) are plotted on the right axis. The first fraction contains the lowest density of 
sucrose (0% before centrifugation) and the last fraction contains the highest density of sucrose (80% 
before centrifugation). Error bars indicate the standard error of the mean of three replicates and are less 
than 5%. 
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Figure 4.20 
Sucrose gradient of GOD and insulin amyloid fibrils. Sample contains 0.6 mg/ml GOD and 1.9 mg/ml 
insulin amyloid fibrils in 16 mM sodium phosphate, pH 7.4. Thioflavin T and Amplex Red assay 
fluorescence readings (clear bars and grey bars, respectively) are plotted on the left axis and Bradford 
assay absorbance readings (dark diamonds) are plotted on the right axis. The first fraction contains the 
lowest density of sucrose (0% before centrifugation) and the last fraction contains the highest density of 
sucrose (80% before centrifugation). Error bars indicate the standard error of the mean of three 
replicates and are less than 5%. 
 
Figure 4.21 
Sucrose gradient of GOD and insulin amyloid fibrils and GA. Sample contains 0.6 mg/ml GOD and 1.9 
mg/ml insulin amyloid fibrils in 16 mM sodium phosphate, pH 7.4 and 1% GA. Thioflavin T and Amplex 
Red assay fluorescence readings (clear bars and grey bars, respectively) are plotted on the left axis and 
Bradford assay absorbance readings (dark diamonds) are plotted on the right axis. The first fraction 
contains the lowest density of sucrose (0% before centrifugation) and the last fraction contains the 
highest density of sucrose (80% before centrifugation). Error bars indicate the standard error of the 
mean of three replicates and are less than 5%. 
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The sucrose gradient results for GOD and insulin amyloid fibrils (Figure 4.20) were a 
combination of the sucrose gradient for GOD (Figure 4.16) and the gradient for insulin amyloid 
fibrils (Figure 4.18). There was a high Amplex Red fluorescence reading in the mid-density 
fractions, and a high ThT reading in the high density fraction. The Bradford assay had a high 
absorbance reading in both of these areas, reflecting the protein concentration of GOD in the 
mid-fractions and the protein concentration of amyloid fibrils in the high density fraction. There 
was a small amount of GOD in the amyloid fibril pellet in the high density fraction. This 
indicated that some of the GOD had been spun through the gradient with the amyloid fibrils. 
This could either be a contamination effect or a non-covalent association of GOD with the 
amyloid fibrils, consistent with earlier results (Section 4.5).  
 
The results for the sucrose gradient of GOD and insulin amyloid fibrils and GA as given in 
Figure 4.21 were very similar to the results for GOD and insulin amyloid fibrils. The 
absorbance readings for the Bradford assay were slightly lower, indicating that there may be 
cross-linking occurring between GOD and insulin amyloid fibrils, as the free amino groups are 
no longer available to react with the Bradford reagent. However, this cross-linking effect on the 
Bradford reading is not seen in the GOD and GA samples. The reason for this trend is not 
known.  
 
The results of the sucrose gradient for crystallin amyloid fibrils (Figure 4.22) showed a high 
fluorescence reading in the high density fraction, similar to the gradient for insulin amyloid 
fibrils (Figure 4.18). There was also a high absorbance reading for the low density fractions. 
This suggests that low molecular weight protein was removed from the fibril sample. This low 
molecular weight protein is likely to be unfibrillised crystallin proteins, due to the incomplete 
fibril formation by crude crystallin. This was also seen in the sucrose gradient results for 
crystallin amyloid fibrils and GA in Figure 4.23; however, all values were much lower. This 
could be due to incomplete resuspension of the crystallin amyloid fibril pellet in the sucrose 
gradient studies due to its transparency. 
 
In the results for the sucrose gradient of GOD and crystallin amyloid fibrils there was low 
molecular weight, unfibrillised crystallins present in the low density fractions (Figure 4.24). 
There was also GOD present in the mid-density fractions, and in the highest density fraction 
with the crystallin amyloid fibrils. Upon addition of GA, there was a higher amount of GOD in 
the high density fraction, suggesting that cross-linking is occurring (Figure 4.25). 
  
Chapter Four – Cross-linking glucose oxidase to amyloid fibrils  78 
 
 
Figure 4.22 
Sucrose gradient of crystallin amyloid fibrils. Sample contains 1.9 mg/ml crystallin amyloid fibrils in 16 
mM sodium phosphate, pH 7.4. Thioflavin T and Amplex Red assay fluorescence readings (clear bars and 
grey bars, respectively) are plotted on the left axis and Bradford assay absorbance readings (dark 
diamonds) are plotted on the right axis. The first fraction contains the lowest density of sucrose (0% 
before centrifugation) and the last fraction contains the highest density of sucrose (80% before 
centrifugation). Error bars indicate the standard error of the mean of three replicates and are less than 
5%. 
 
Figure 4.23 
Sucrose gradient of crystallin amyloid fibrils and GA. Sample contains 1.9 mg/ml crystallin amyloid 
fibrils in 16 mM sodium phosphate, pH 7.4 and 1% GA. Thioflavin T and Amplex Red assay fluorescence 
readings (clear bars and grey bars, respectively) are plotted on the left axis and Bradford assay 
absorbance readings (dark diamonds) are plotted on the right axis. The first fraction contains the lowest 
density of sucrose (0% before centrifugation) and the last fraction contains the highest density of sucrose 
(80% before centrifugation). Error bars indicate the standard error of the mean of three replicates and 
are less than 5%. 
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Figure 4.24 
Sucrose gradient of GOD and crystallin amyloid fibrils. Sample contains 0.6 mg/ml GOD and 1.9 mg/ml 
crystallin amyloid fibrils in 16 mM sodium phosphate, pH 7.4. Thioflavin T and Amplex Red assay 
fluorescence readings (clear bars and grey bars, respectively) are plotted on the left axis and Bradford 
assay absorbance readings (dark diamonds) are plotted on the right axis. The first fraction contains the 
lowest density of sucrose (0% before centrifugation) and the last fraction contains the highest density of 
sucrose (80% before centrifugation). Error bars indicate the standard error of the mean of three 
replicates and are less than 5%. 
 
Figure 4.25 
Sucrose gradient of GOD and crystallin amyloid fibrils and GA. Sample contains 0.6 mg/ml GOD and 
1.9 mg/ml crystallin amyloid fibrils and GA in 16 mM sodium phosphate, pH 7.4. Thioflavin T and 
Amplex Red assay fluorescence readings (clear bars and grey bars, respectively) are plotted on the left 
axis and Bradford assay absorbance readings (dark diamonds) are plotted on the right axis. The first 
fraction contains the lowest density of sucrose (0% before centrifugation) and the last fraction contains 
the highest density of sucrose (80% before centrifugation). Error bars indicate the standard error of the 
mean of three replicates and are less than 5%. 
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These sucrose gradient results suggest that there is some cross-linking occurring both between 
GOD and insulin amyloid fibrils and GOD and crystallin amyloid fibrils. Overall, the sucrose 
gradient centrifugation method proved to be a successful technique for separating free GOD 
from immobilised GOD as there was minimal contamination and distinct separation of free 
GOD, immobilised GOD, and unfibrillised protein into sucrose fractions of different densities.  
 
 
4.7 Microscopy studies 
 
TEM is routinely used for the identification of amyloid fibrils, and has been used to assess the 
effect of enzyme immobilisation on other structures such as carbon nanotubes (Hrapovic et al. 
2004; Nilsson 2004). The technique was employed to assess the effect of GOD immobilisation 
on the morphology of amyloid fibrils. The structures and morphologies of GOD-functionalised 
amyloid fibrils were viewed by TEM and representative images of cross-linked samples and 
controls are shown in Figure 4.26.  
 
The GOD dimer has dimensions of approximately 6 x 5.2 x 7.7 nm, as determined by 
crystallography (Hecht et al. 1993), so may be able to be visualised by TEM. However, grid 
assembly and staining may cause the GOD dimer to be in a denatured anhydrous state. Previous 
work involving AFM of GOD cross-linked to carbon nanotubes reported the height of dry GOD 
to be around 1 nm (Besteman et al. 2003). The small rounded structures seen in the GOD and 
GOD and GA controls (Figure 4.26A and B, respectively) could be dry enzyme, as the average 
size of the small particles is around 1 nm in diameter. GOD gives a cloudy pattern when 
visualised by TEM, and the addition of GA causes the formation of denser cloud structures, 
consistent with the presence of intermolecular cross-links.  
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Figure 4.26 
Representative TEM images of cross-linked samples and controls. 0.6 mg/ml GOD (A), 0.6 mg/ml GOD, 
1% GA (B), 1.9 mg/ml insulin fibrils (C), 1.9 mg/ml insulin fibrils, 1% GA (D), 1.9 mg/ml insulin fibrils, 
0.6 mg/ml GOD (E), 1.9 mg/ml insulin fibrils, 0.6 mg/ml GOD, 1% GA (F), 1.9 mg/ml crystallin fibrils 
(G), 1.9 mg/ml crystallin fibrils, 1% GA (H), 1.9 mg/ml crystallin fibrils, 0.6 mg/ml GOD (I), 1.9 mg/ml 
crystallin fibrils, 0.6 mg/ml GOD and 1% GA (J). Scale bar = 0.2 µm. 
 
 
4.8 Differential scanning fluorimetry (DSF) 
 
DSF measures the temperature at which a protein unfolds using a dye called Sypro-orange, 
which has an affinity for hydrophobic protein, exposed as the protein unfolds (Niesen et al. 
2007). The binding of the dye to unfolded protein produces a measurable fluorescence emission 
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(Ericsson et al. 2006). This technique was performed on cross-linked samples to test thermal 
stability of the cross-linked enzyme, as shown in Figure 4.27. Previously obtained values for the 
thermal denaturation of GOD, state that GOD loses tertiary structure at 61°C, with loss of the 
FAD cofactor at 61°C (Gouda et al. 2003). The result for GOD alone is consistent with these 
literature values, where thermal denaturation occurred at around 59°C. The sample containing 
GOD and insulin amyloid fibrils had a greater thermal stability than the sample containing 
native GOD, denaturing at around 67°C. Samples containing GA interfered with the Sypro-
orange dye, giving a high initial fluorescence reading and thus a high signal to noise ratio and 
therefore no thermal denaturation temperature was obtained for these samples. There was no 
observed denaturation of amyloid fibrils, indicating their high stability. 
 
 
Figure 4.27 
DSF of cross-linked samples. Cross-linked samples and controls: Non-protein control (black), GOD 
(blue), GOD and GA (red), insulin amyloid fibrils (green), insulin amyloid fibrils and GA (purple), GOD 
and insulin amyloid fibrils (pink) and GOD, insulin amyloid fibrils and GA (orange). Curves are drawn 
from the average of three replicates.  
 
DSF data were corroborated by heating the samples in 10°C increments in an independent 
experiment and testing for GOD activity using the Amplex red assay, as shown in Figure 4.28. 
These results showed that the immobilisation of GOD onto insulin amyloid fibrils decreased the 
activity of GOD at lower temperatures. However, immobilisation of GOD onto amyloid fibrils 
was associated with the significantly higher activity observed at temperatures above 70 °C for 
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these samples, such as at 70 °C. The melting temperature results of the DSF and thermal 
denaturation studies are summarised in Table 4.1. These results show a similar melting 
temperature obtained from both studies. 
 
 
Figure 4.28 
Thermal denaturation of cross-linked samples. GOD (blue), GOD and GA (red), GOD and insulin 
amyloid fibrils (green) and GOD and insulin fibrils and GA (purple).  
 
Table 4.1 
Melting temperature results of cross-linked samples. The cross-linked samples and their melting 
temperature as determined by DSF and thermal denaturation experiments are given. DSC melting 
temperature is taken from peak maximum and thermal denaturation melting temperature is taken from 
point of decrease in GOD activity.  
 
Cross-linked Sample DSF (°C) Thermal Denaturation (°C) 
GOD 61 60 
GOD and GA - 60 
GOD and insulin amyloid fibrils 67 70 
GOD, insulin amyloid fibrils and GA - 70 
 
To further corroborate the data from the DSF and thermal denaturation experiments, the 
samples were examined using a CD spectrometer, which measures protein unfolding along a 
temperature gradient. However, the samples had a very high absorbance and voltage threshold 
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for the CD spectrometer, and did not produce reliable results. Further experiments such as 
differential scanning colorimetry (DSC) are needed to ascertain the effect of immobilisation on 
the thermal stability of GOD. DSC uses measurement of heat input and output to assess protein 
denaturation, as opposed to the use of optical light by the CD spectrometer, and thus may be a 
more effective measure of thermal stability (Grant Pearce, Personal Communication). 
 
 
4.9 Conclusion 
 
The SDS-PAGE, centrifugation and TEM methods used in this chapter provided a suite of 
effective tools for assessing the degree of cross-linking in high molecular weight samples. 
These experiments also provide a model for assessment of cross-linking using other enzymes in 
the future. The melting temperature of immobilised GOD was found to be similar to that of free 
GOD. However, the techniques employed were subject to interference from the amyloid fibrils. 
The use of experiments which minimise this effect are required to confirm enzyme stability 
upon immobilisation in the future. 
 
The results in this chapter show that GOD can be cross-linked to both bovine insulin and 
crystallin amyloid fibrils, to form an amyloid fibril enzyme scaffold that retains GOD activity, 
thus providing a ‘proof of concept’ model for enzyme attachment to amyloid fibrils.  
 
The ability to increase the number of intermolecular cross-links between amyloid fibrils and 
GOD was investigated in Chapter Five via deglycosylation and via oxidation of the glycoprotein 
shell. 
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5. CHAPTER FIVE - ALTERNATIVE 
METHODS OF CROSS-LINKING 
GLUCOSE OXIDASE TO AMYLOID 
FIBRILS 
 
 
5.1 Introduction 
 
In Chapter Three, the ability to attach native GOD to amyloid fibrils using GA was investigated. 
Cross-linking by glutaraldehyde is dependent on the presence of free amino groups on the 
surface of the enzyme, provided by the amino acids lysine and arginine (Wine et al. 2007). The 
glycoprotein shell on native GOD may influence the binding of glutaraldehyde to surface lysine 
residues, by limiting access of the cross-linker to free amine groups, as the structure of the 
carbohydrate shell remains unknown (Kalisz et al. 1991). Thus, in this chapter, the ability to 
modify the glycoprotein shell to achieve a higher degree of cross-linking was investigated. Two 
methods were used to modify the glycoprotein shell, deglycosylation and oxidation. 
Deglycosylation involves removal of the shell using sugar-cleaving enzymes, and oxidation 
involves the formation of aldehyde groups on the sugar molecules using periodate. Methods 
used in this chapter to assess the degree of cross-linking were SDS-PAGE and sucrose gradient 
centrifugation, as described in Chapter Four. 
 
 
5.2 Deglycosylation of GOD 
 
Native GOD consists of a protein core which is partially surrounded by a carbohydrate shell 
(Wilson and Turner 1992). GOD was deglycosylated using the enzymes α-mannosidase and 
endoglycosidase H, a combination that has been widely used for the removal of the glycoprotein 
shell of GOD (Sohail Akhtar and Bhakuni 2003). As mentioned in Section 1.8, the carbohydrate 
shell of GOD consists of 190 mannose residues and 16 N-acetylglucosamine residues, which are 
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N- or O-glycosidically linked to the enzyme (Kalisz et al. 1991). α-Mannosidase is a non-
linkage specific glycosidase, and endoglycosidase H is useful for the cleavage of mannose 
(Tarentino and Maley 1974; Burrows and Rastall 1998).  
 
 
5.2.1 Ninhydrin 
 
The effect of deglycosylation on the availability of lysine residues for cross-linking was 
assessed using a ninhydrin test. The number of ε-amino groups and N-terminal amines can be 
determined by reaction with ninhydrin solution following denaturation at high temperature 
(Friedman and Williams 1973). Thus the ninhydrin test can be used to compare the number of 
lysine residues available for cross-linking before and after deglycosylation. This test has been 
previously used to test the number of free amines of chitosan, before and after GOD 
immobilisation (Wei et al. 2002). 
 
The ninhydrin test was carried out on deglycosylated GOD cross-linked samples and native 
GOD cross-linked samples. Control curves were created for BSA and native GOD, where the 
absorbance of GOD was higher than that of BSA, reflecting the amino acid content. BSA has 
been used in previous research as a standard for ninhydrin-based assays (Starcher 2001). The 
results obtained for the cross-linked samples are given in Table 5.1. 
 
Table 5.1 
Ninhydrin results for cross-linked GOD and deglycosylated cross-linked GOD. The GOD sample and 
associated ninhydrin absorbance readings are given below. The error values show the standard error of 
the mean of three replicates of less than 5%.  
 
Sample Absorbance 
at 570 nm 
Calculated Molar 
Concentration 
(Lysine) (M) 
Absorbance/Available 
Lysine 
0.6 mg/ml GOD 0.100 ± 0.003 1.87 x 10-5 5.33 x 103
0.6 mg/ml GOD, 1.9 mg/ml insulin 
amyloid fibrils and 1% GA 
0.024 ± 0.002 - - 
0.075 mg/ml deglycosylated GOD 0.950 ± 0.001 1.41 x 10-5 6.70 x 104
0.075 mg/ml deglycosylated GOD, 
0.24 mg/ml insulin amyloid fibrils and 
0.125% GA 
0.244 ± 0.002 - - 
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The number of free amine groups can be calculated from the ninhydrin absorbance data in Table 
5.1 and the reported of available surface lysine residues in the literature (Baszkin et al. 1997). 
The results of these calculations are summarised in Table 5.2.  
 
Table 5.2 
Calculation of available lysine residues from ninhydrin data. The number of available lysine residues in 
deglycosylated GOD can be calculated from the reported number of available lysine residues given for 
native GOD in the literature and the calculated absorbance per lysine residue from Table 5.1, and vice 
versa. 
 
Sample Available Lysine (Literature) Calculated Available Lysine 
0.6 mg/ml GOD 7 0.39 
0.075 mg/ml deglycosylated GOD 26 302 
 
 
These results showed that the degree of ninhydrin reaction greatly increased upon 
deglycosylation of GOD. However, the calculated number of lysine residues before 
deglycosylation is significantly lower than the literature value, and the number of lysine 
residues available after deglycosylation is significantly higher than the literature value, based on 
the amino acid sequence of GOD (30 lysine residues). The number of lysine residues 
contributed by small quantities of cleavage enzymes (calculation not shown), is negligible and 
does not account for the significant difference.  
 
If the obtained value for deglycosylated GOD is assumed to be correct, the calculated number of 
available lysine residues in native GOD suggests variation between glycoforms of GOD used in 
the literature compared to this thesis. Conversely, if the obtained value for GOD is assumed to 
be correct, the calculated number of free lysine residues suggests that hydrolysis is occurring 
within the protein, accounting for a large number of N-terminal amino groups in the sample. 
From these results, it was concluded that the use of ninhydrin to quantify the number of free 
lysine residues in GOD may be inaccurate. However, qualitatively, the results given in Table 
5.1 indicate that deglycosylation is successful and, further, the number of free amino groups has 
decreased upon addition of GA in both the native and deglycosylated GOD samples, suggesting 
that cross-linking is occurring. Further experiments are required to quantify the degree of this 
cross-linking.    
 
Ch
 
5.
 
Th
ge
th
 
 
Fi
SD
in 
ad
am
(4)
bu
1%
 
In
m
re
ba
of
hi
apter Five –
2.2 Electr
e deglycosy
l, as describ
e cross-linke
gure 5.1 
S-PAGE of 
lanes contai
justed to pH
yloid fibrils 
, 1.9 mg/ml i
ffer adjusted 
 GA adjusted
 Figure 5.1
olecular wei
ported as 61
nds in Lane 
 the deglyco
gher value t
 Alternative
ophoretic s
lated enzym
ed for the n
d samples a
deglycosylate
ning 0.6 mg/
 7.0 (1), deg
adjusted to pH
nsulin amyloi
to pH 7.0 (5)
 to pH 7.0 (6)
, deglycosy
ght (Lane 1)
 kDa for the
1 (Bands a, 
sylated GOD
han the liter
 methods of 
tudies 
e was cross
ative enzym
nd controls a
d GOD cross
ml deglycosy
lycosylated G
 7.0 (3), 1.9
d fibrils and 
, and 1.9 mg/
.   
lated GOD 
. The molec
 monomer an
b), at 65 kD
 monomer 
ature (Lesko
a 
e 
b 
d 
c 
cross-linkin
-linked usin
e in Section
re given in F
-linking to in
lated GOD in
OD and 1%
 mg/ml insul
0.6 mg/ml deg
ml insulin am
resulted in
ular weight 
d 110 kDa 
a and 140 kD
and dimer, 
vac et al. 2
g glucose ox
g glutaralde
 2.4.1. The 
igure 5.1. 
sulin amyloid
 10 mM pot
 GA adjuste
in amyloid fib
lycosylated G
yloid fibrils, 
 several ba
for deglycos
for the dime
a, were con
respectively
005), which
idase to amy
hyde and ru
results for th
 fibrils. Band
assium phosp
d to pH 7.0 
rils and 1% 
OD in 10 mM
0.6 mg/ml de
nds ranging
ylated GOD
r (Kalisz et 
sistent with 
. The dimer 
 could be du
loid fibrils 
n on an SD
e SDS-PAG
s produced b
hate buffer a
(2), 1.9 mg/m
GA adjusted 
 potassium p
glycosylated 
 from low
 has been pr
al. 1991). Tw
the molecula
band (Band
e to a sligh
91 
S-PAGE 
E gel of 
y samples 
t pH 5.0 
l insulin 
to pH 7.0 
hosphate 
GOD and 
to high 
eviously 
o of the 
r weight 
 a) has a 
tly lower 
Chapter Five – Alternative methods of cross-linking glucose oxidase to amyloid fibrils 92 
 
efficiency of deglycosylation. This shows a 12 – 18 % drop in molecular weight from the native 
enzyme, where the molecular weight of the monomer was ~80 kDa and the molecular weight of 
the dimer was 160 kDa (Section 1.8). This result is in agreement with the molecular weight of 
the GOD amino acid sequence, calculated at 63.2 kDa (Frederick et al. 1990). There were 
smaller bands at around 66 kDa and 44 kDa (Bands c, e), which are consistent with the 
molecular weights of the α-mannosidase monomers. α-Mannosidase is a heterotetramer 
containing a two subunits of 66 kDa and two subunits of 44 kDa, which appear as two distinct 
bands on an SDS-PAGE gel (Burrows and Rastall 1998). Endoglycosidase H has a molecular 
weight of ~27 kDa when run on an SDS-PAGE gel (Tarentino and Maley 1974). There was no 
endoglycosidase H band visible, as the enzyme was at very low concentration and thus unable 
to be visualised on a gel. There was a faint band present at 55 kDa (Band d) which is 
inconsistent with any molecular weight of the proteins in solution, and thus may be an impurity 
in the enzyme preparation. This would be confirmed by running the enzymes α-mannosidase 
and endoglycosidase H on a gel; however, this was not feasible due to the high cost and limited 
supply of the endoglycosidase H enzyme. Upon addition of GA (Lane 2), the GOD bands 
remained unchanged.  
 
There were no bands visible in the insulin amyloid fibrils or insulin amyloid fibrils and GA 
samples (Lane 3, 4), consistent with previous results in Section 4.3.1, Figure 4.2. When 
deglycosylated GOD was added to insulin amyloid fibrils, the bands seen for the deglycosylated 
GOD sample remained unchanged (Lane 5). This suggests that the non-covalent association 
seen between amyloid fibrils and GOD in Section 4.3.1 may involve the carbohydrate shell of 
the enzyme. Upon addition of GA (Lane 6), all deglycosylated GOD bands were diminished in 
intensity, confirmed by densitometry (data not included). This indicates that some of the 
deglycosylated GOD remained in the wells of the gel with the insulin amyloid fibrils, consistent 
with cross-linking. To assess the degree of cross-linking, samples were then spun in a sucrose 
gradient. 
 
 
5.2.3 Centrifugation studies 
 
Cross-linked deglycosylated samples and their associated controls were analysed by 
centrifugation through a sucrose gradient to separate free GOD from immobilised GOD, as 
described in Section 4.4. Fractions from the gradient were again tested for GOD activity using 
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the Amplex Red assay, the presence of amyloid fibrils using the ThT assay, and the protein 
concentration using the Bradford assay.  
 
The sucrose gradient results for free deglycosylated GOD are shown in Figure 5.2. In the 
Amplex Red assay, there was a large amount of fluorescence seen in the mid-range densities of 
the sucrose gradient (Fractions 4 and 5). This was mirrored in the results of the Bradford assay. 
There was low fluorescence in the ThT assay for all fractions, consistent with previous results 
for free native GOD (Figure 4.16). Similar results were obtained for the sucrose gradient of 
deglycosylated GOD and GA (Figure 5.3). However, there was a small amount of fluorescence 
observed in the high sucrose density samples (Fractions 8 and 9). This is consistent with all 
other GOD and GA results, and is likely to be auto-fluorescent products of the GA reaction due 
to ageing of the GA, as discussed in Section 4.4.   
 
The sucrose gradient results for insulin amyloid fibrils are given in Figure 5.4. These results are 
consistent with previous sucrose gradient results for insulin amyloid fibrils in Chapter Four, 
where there was a large amount of ThT fluorescence visible in the highest density sucrose 
sample (Fraction 9). There was no significant fluorescence seen in any of the fractions in the 
Amplex Red assay, or any significant absorbance seen in any of the fractions in the Bradford 
assay. This result was unchanged upon addition of GA, as shown in Figure 5.5. 
 
The sucrose gradient results for GOD and insulin amyloid fibrils are given in Figure 5.6. These 
results were a combination of the sucrose gradient for deglycosylated GOD (Figure 5.2) and the 
gradient for insulin amyloid fibrils (Figure 5.4). There was a high Amplex Red fluorescence 
reading in the mid-density fractions (Fractions 3 and 4) and a high ThT fluorescence reading in 
the highest density fraction (Fraction 9). The Bradford assay has a high absorbance in both of 
these areas, reflecting the protein concentration of GOD in the mid-density fractions, and the 
protein concentration of the amyloid fibrils in the high density fraction. There was a small 
amount of GOD in the amyloid fibril pellet in the high density fraction (Fraction 9). This 
indicated that some of the GOD had been spun through the gradient with the amyloid fibrils, 
consistent with the effect seen in the native GOD and amyloid fibrils samples in Chapter Four. 
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Figure 5.2 
Sucrose gradient profile of deglycosylated GOD. Thioflavin T assay results (white bars) and Amplex Red 
assay results (grey bars) are plotted on the left axis, and Bradford assay results (dark diamonds) are 
plotted on the right axis. Error bars indicate standard error of the mean of three replicates and are less 
than 5%. Values are corrected for fluorescence or absorbance of control. 
 
 
Figure 5.3 
Sucrose gradient profile of deglycosylated GOD and GA. Thioflavin T assay results (white bars) and 
Amplex Red assay results (grey bars) are plotted on the left axis, and Bradford assay results (dark 
diamonds) are plotted on the right axis. Error bars indicate standard error of the mean of three replicates 
and are less than 5%. Values are corrected for fluorescence or absorbance of control.  
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Figure 5.4 
Sucrose gradient profile of insulin amyloid fibrils. Thioflavin T assay results (white bars) and Amplex 
Red assay results (grey bars) are plotted on the left axis, and Bradford assay results (dark diamonds) are 
plotted on the right axis. Error bars indicate standard error of the mean of three replicates and are less 
than 5%. Values are corrected for fluorescence or absorbance of control. 
 
Figure 5.5 
Sucrose gradient profile of insulin amyloid fibrils and GA. Thioflavin T assay results (white bars) and 
Amplex Red assay results (grey bars) are plotted on the left axis, and Bradford assay results (dark 
diamonds) are plotted on the right axis. Error bars indicate standard error of the mean of three replicates 
and are less than 5%. Values are corrected for fluorescence or absorbance of control. 
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Figure 5.6 
Sucrose gradient profile of insulin amyloid fibrils and deglycosylated GOD. Thioflavin T assay results 
(white bars) and Amplex Red assay results (grey bars) are plotted on the left axis, and Bradford assay 
results (dark diamonds) are plotted on the right axis. Error bars indicate standard error of the mean of 
three replicates and are less than 5%. Values are corrected for fluorescence or absorbance of control. 
 
 
Figure 5.7 
Sucrose gradient profile of insulin amyloid fibrils, deglycosylated GOD and GA. Thioflavin T assay 
results (white bars) and Amplex Red assay results (grey bars) are plotted on the left axis, and Bradford 
assay results (dark diamonds) are plotted on the right axis. Error bars indicate standard error of the 
mean of three replicates and are less than 5%. Values are corrected for fluorescence or absorbance of 
control. 
-0.050
0.000
0.050
0.100
0.150
0.200
0.250
0.300
0.350
0.400
-1000
0
1000
2000
3000
4000
5000
6000
7000
8000
1 2 3 4 5 6 7 8 9
A
bs
or
ba
nc
e 
(A
U
)
R
el
at
iv
e 
Fl
uo
re
sc
en
ce
 (R
FU
)
Sucrose Gradient Fraction
Thioflavin T Assay Amplex Red Assay Bradford Assay
-0.050
0.000
0.050
0.100
0.150
0.200
0.250
-500
0
500
1000
1500
2000
2500
1 2 3 4 5 6 7 8 9
A
bs
or
ba
nc
e 
(A
U
)
R
el
at
iv
e 
Fl
uo
re
sc
en
ce
 (R
FU
)
Sucrose Gradient Fraction
Thioflavin T Assay Amplex Red Assay Bradford Assay
Chapter Five – Alternative methods of cross-linking glucose oxidase to amyloid fibrils 97 
 
The results for the sucrose gradient of GOD and insulin amyloid fibrils and GA (Figure 5.7) 
were very similar to the results for GOD and insulin amyloid fibrils. The absorbance readings 
for the Bradford assay were slightly lower, indicating that there may be cross-linking occurring 
between GOD and insulin amyloid fibrils, as the free amino groups are no longer available to 
react with the Bradford reagent. This is similar to the results obtained for native GOD and 
insulin amyloid fibrils and GA. 
 
Deglycosylation is thus an effective method for removal of the glycoprotein shell of GOD, 
resulting in the increased availability of free amino groups for cross-linking, as shown by the 
ninhydrin test. However, the increased availability of free amino groups does not result in a 
significant increase in cross-linking. In previous research, deglycosylation was found to increase 
amount of enzyme loading, but not increase the specific activity of the enzyme (Volponi et al. 
2008). This indicates that deglycosylated GOD may be cross-linking to amyloid fibrils with 
higher loading, but with no gain in activity. Deglycosylation was therefore not pursued further. 
 
 
5.3 Oxidation of GOD by periodate 
 
Another possible method of attachment of GOD to amyloid fibrils involves exploitation of the 
carbohydrate shell of GOD. Oxidation of the sugar molecules on the surface of the glycoprotein 
results in the formation of aldehyde groups, which can react with amines to produce an imine 
(Kozulic et al. 1987). In this way, the sugar residues could be used to cross-link GOD to the free 
amines on amyloid fibrils via reduction. The ability to cross-link GOD to amyloid fibrils via 
oxidation of the glycoprotein shell was investigated using the gel electrophoresis and 
centrifugation techniques used previously. 
 
 
5.3.1 Electrophoretic studies 
 
The use of sodium periodate to oxidise the hydroxyl groups of mannose residues on the surface 
of GOD to reactive aldehydes is an established method (Kozulic et al. 1987; Yoon et al. 2000). 
These aldehyde groups can then react with free amines, to form a Schiff base intermediate, 
which is in equilibrium with the starting materials (Zhang et al. 2004). This cross-linking 
experiment was designed to create reactive aldehydes on GOD that could form Schiff base 
intermediates with the free amino groups on amyloid fibrils. This Schiff base intermediate could 
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glycoprotein shell of the enzyme that destabilised the dimer. The highest concentration of 
sodium periodate (Lane 8) was chosen for further experiments.  
 
To determine the appropriate concentration of sodium borohydride to achieve optimal cross-
linking to amyloid fibrils, several concentrations of sodium borohydride were used to reduce the 
reactive aldehyde groups on the GOD sample that had been oxidised with a molar ratio of 
sodium periodate of 2:1. As the concentration of sodium borohydride increased, there was 
increased reduction of aldehyde groups on GOD, so the highest sodium borohydride 
concentration was chosen for further experiments (data not shown).  
 
The ability to attach GOD to amyloid fibrils using carbohydrate oxidation and subsequent Schiff 
base reduction was then investigated. Oxidised GOD was added to insulin amyloid fibrils and 
reduced using sodium borohydride, at a molar ratio of sodium borohydride to mannose of 100:1. 
The results of the cross-linking experiment using shell oxidation are given in Figure 5.9. 
 
The oxidised GOD sample (Lane 1) produced one major band, consistent with the molecular 
weight of the GOD monomer at ~80 kDa. Upon addition of sodium borohydride (Lane 2), two 
bands are produced at ~80 and 160 kDa (indicated with arrow), consistent with the molecular 
weight of the GOD monomer and dimer, respectively. Insulin amyloid fibrils (Lane 3) did not 
produce any bands, consistent with previous results (Section 4.3.1, Figure 4.2). This remained 
unchanged upon addition of sodium borohydride.  
 
The GOD and insulin amyloid fibrils sample produced a band with a molecular weight of ~80 
kDa, consistent with the molecular weight of the monomer (Lane 5). Upon addition of sodium 
borohydride, only the monomer band was visible (Lane 6). This indicates that cross-linking is 
occurring, as the dimeric band seen in the GOD and sodium borohydride sample (Lane 2) is no 
longer visible, suggesting that GOD is attached to the amyloid fibrils. The monomer may also 
be binding; however, a difference in band density is not visible. 
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Figure 5.10 
Sucrose gradient profile for oxidised GOD. Thioflavin T assay results (clear bars) and Amplex Red 
assay results (grey bars) are plotted on the left axis, and Bradford assay results (dark diamonds) are 
plotted on the right axis. Error bars indicate standard error of the mean of three replicates and are less 
than 5%. 
 
Figure 5.11 
Sucrose gradient profile for cross-linked oxidised GOD. Thioflavin T assay results (clear bars) and 
Amplex Red assay results (grey bars) are plotted on the left axis, and Bradford assay results (dark 
diamonds) are plotted on the right axis. Error bars indicate standard error of the mean of three replicates 
and are less than 5%. 
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Figure 5.12 
Sucrose gradient profile for insulin amyloid fibrils. Thioflavin T assay results (clear bars) and Amplex 
Red assay results (grey bars) are plotted on the left axis, and Bradford assay results (dark diamonds) are 
plotted on the right axis. Error bars indicate standard error of the mean of three replicates and are less 
than 5%.. 
 
 
Figure 5.13 
Sucrose gradient profile for insulin amyloid fibrils with sodium borohydride. Thioflavin T assay results 
(clear bars) and Amplex Red assay results (grey bars) are plotted on the left axis, and Bradford assay 
results (dark diamonds) are plotted on the right axis. Error bars indicate standard error of the mean of 
three replicates and are less than 5%. 
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Figure 5.14 
Sucrose gradient profile for insulin amyloid fibrils and oxidised GOD. Thioflavin T assay results (clear 
bars) and Amplex Red assay results (grey bars) are plotted on the left axis, and Bradford assay results 
(dark diamonds) are plotted on the right axis. Error bars indicate standard error of the mean of three 
replicates and are less than 5%. 
 
 
Figure 5.15 
Sucrose gradient profile for insulin amyloid fibrils and oxidised GOD with sodium borohydride. 
Thioflavin T assay results (clear bars) and Amplex Red assay results (grey bars) are plotted on the left 
axis, and Bradford assay results (dark diamonds) are plotted on the right axis. Error bars indicate 
standard error of the mean of three replicates and are less than 5%. 
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The sucrose gradient results for oxidised GOD are shown in Figure 5.10. There was a large 
amount of fluorescence produced in the mid-density samples (Fractions 3 - 5) in the Amplex 
Red assay, consistent with previous results for native GOD. This is mirrored in the results of the 
Bradford assay, where there was a high absorbance in the mid-density samples. There was no 
significant fluorescence produced in any of the samples in the ThT assay. This result is 
unchanged upon addition of sodium borohydride (Figure 5.11).  
 
The sucrose gradient results for insulin amyloid fibrils are given in Figure 5.12. There is a high 
amount of ThT fluorescence in the high density sucrose sample (Fraction 9). This is mirrored in 
the results of the Bradford assay, where there is a high absorbance in the high density sample. 
There is no significant absorbance in any of the fractions in the Amplex Red assay. This is 
consistent with previous results for unmodified insulin amyloid fibrils in Section 4.3.1 (Figure 
4.2). 
 
There is little change upon addition of sodium borohydride in the Amplex Red and ThT assays 
(Figure 5.13). However, in the Bradford assay, there is a small absorbance in the low density 
sucrose samples (Fractions 1-3). This may be low molecular weight protein due to reduction of 
the amyloid fibrils by sodium borohydride, causing destabilisation of the amyloid fibril 
structure.  
 
The sucrose gradient results for oxidised GOD and insulin amyloid fibrils are shown in Figure 
5.14. These results were a combination of the sucrose gradient for oxidised GOD (Figure 5.10) 
and insulin amyloid fibrils (Figure 5.12). There was a high Amplex Red fluorescence reading in 
the mid-density fractions (Fractions 3 - 5) and a high ThT fluorescence reading in the highest 
density fraction (Fraction 9). The Bradford assay has a high absorbance in both of these areas, 
reflecting the protein concentration of GOD in the mid-fractions, and the protein concentration 
of the amyloid fibrils in the high density fraction. There is a very small amount of GOD in the 
amyloid fibril pellet in the high density fraction (Fraction 9). This indicates that some of the 
GOD had been spun through the gradient with the amyloid fibrils, suggesting an association 
effect. 
 
The sucrose gradient results for oxidised GOD and insulin amyloid fibrils treated with sodium 
borohydride are given in Figure 5.15. These results showed a high Amplex Red fluorescence 
reading in the mid-density fractions (Fractions 3 - 5) and a high ThT fluorescence reading in the 
highest density fraction (Fraction 9). The Bradford assay has a high absorbance in both of these 
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areas, reflecting the protein concentration of GOD in the mid-fractions, and the protein 
concentration of the amyloid fibrils in the high density fraction. There was a small absorbance 
in the Bradford assay in the low density sucrose fractions (Fractions 1 – 3), as previously seen 
in the reduced insulin amyloid fibrils sample (Figure 5.13). There was also a small absorbance 
reading in the highest density fraction (Fraction 9) in the Amplex Red assay. This indicated that 
some of the GOD had been spun through the gradient with the amyloid fibrils; however, this is a 
small effect compared to the effect seen in the native GOD and amyloid fibrils samples in 
Chapter Four. 
 
Thus the use of sodium periodate is an effective method for oxidation of the glycoprotein shell 
of GOD. However, the use of sodium borohydride as a reducing agent may have a destabilising 
effect on the insulin amyloid fibrils, resulting in decreased attachment. The use of oxidation of 
the glycoprotein shell of GOD followed by reduction using sodium borohydride is therefore not 
as effective as the use of glutaraldehyde as a cross-linking agent. 
 
 
5.4 Conclusions 
 
Deglycosylation of GOD generates clean GOD bands and an increase in reactive lysine groups 
for use in GA cross-linking. However, the results of the sucrose gradient studies do not greatly 
differ from the results achieved with native GOD. The deglycosylation is both expensive and 
time consuming, and therefore is not the most effective method of cross-linking GOD to 
amyloid fibrils.  
 
Oxidation of the carbohydrate shell of GOD results in reactive aldehyde groups which can, in 
turn, react with the amines of amyloid fibrils to form imine bonds. This technique was effective 
in cross-linking GOD to amyloid fibrils. However, due to the amount of time taken to achieve 
this result, and the loss of amyloid fibrils by reaction with sodium borohydride, further method 
development is needed. Thus, cross-linking GOD to amyloid fibrils via GA is the most effective 
method of cross-linking. 
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6. CHAPTER SIX - INCORPORATING 
FUNCTIONALISED AMYLOID 
FIBRILS INTO A PVOH FILM SYSTEM 
 
 
6.1 Introduction 
 
Previous results described in Chapters Three and Four demonstrated the ability to use amyloid 
fibrils as a nanoscaffold for enzyme immobilisation. These functionalised amyloid fibrils have 
the potential to be incorporated into a film system for the creation of a new bionanomaterial.  
 
The material used in the model film system in this chapter was poly(vinyl alcohol) (PVOH). As 
discussed in Section 1.12, PVOH is an ideal film system for investigating the ability to 
incorporate an enzyme scaffold, as it is inexpensive, readily available, and provides a 
favourable environment for the enzyme (Wong and Abdul-Aziz 2008). PVOH has been widely 
used in biomaterial research because of its elasticity, good film forming ability and water 
content similar to that of biological tissue (Wong and Abdul-Aziz 2008). This is important for 
limiting dehydration and denaturation of immobilised enzymes, which are common problems 
that can occur upon film drying, resulting in loss of enzyme structure and function (Kim et al. 
2008). PVOH provides a stable environment for GOD by hydrogen bonding the H atoms of 
alcohol groups in the PVOH to the O atoms of glycoprotein shell carbohydrate groups in GOD, 
which inhibits unfavourable conformations of GOD (Wong and Abdul-Aziz 2008). The 
immobilisation of GOD and retention of its active conformation provides potential for the 
production of a film with antimicrobial activity, due to the hydrogen peroxide and gluconic acid 
produced in the GOD reaction, useful in the production of antimicrobial packaging (Vartiainen 
et al. 2005). Also, as previously described in Section 1.12, PVOH is known to have selective 
permeability for low molecular weight substances such as glucose, the substrate of the GOD-
catalysed reaction (Wong and Abdul-Aziz 2008). This is an advantage for the production of 
antimicrobial films, as it allows preparation of the film without the addition of glucose, 
simplifying the film preparation method.   
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Despite the favourable properties of PVOH film for enzyme immobilisation, some properties of 
PVOH make the film less suitable for the production of a biomaterial, such as a high degree of 
crystallisation (Chang and Kim 2007). This causes PVOH film to be stiff and brittle; however, 
the addition of amyloid fibrils to PVOH films was predicted to change these properties. The 
addition of the immobilised enzyme scaffold may also provide useful properties such as 
prevention of desorption or leeching out of enzyme, which is a common problem with enzyme-
film preparations (Gade et al. 2006).  
 
In this chapter, the incorporation of the functionalised amyloid fibril scaffold into PVOH was 
investigated as a ‘proof of concept’ material to establish the potential use of amyloid fibrils as a 
nanoscaffold. Microscopy techniques were used to assess the spatial arrangement and mixing of 
film components, and the functionalised film was tested for antimicrobial activity.  
 
 
6.2 Assessment of the contents of functionalised films 
 
PVOH films were prepared using an established in-house solution casting method, as mentioned 
in Section 2.5 (Rao 2008). Cross-linked samples and controls were directly added to dissolved 
PVOH. Cross-linking was performed at a solution pH of 7.0. Upon addition of PVOH, the new 
solution pH was 5.0. This may have an effect on the distribution of amyloid fibrils throughout 
the film, due to increased clumping of fibrils at increasing pH (Chapter Three, Section 3.7). The 
solutions were mixed by inversion, taking care to reduce air bubbles, and cast in a rectangular 
gel casting tray (7 x 10 cm) to obtain equal sized films. The casting trays were measured with a 
spirit level to ensure the films were of even thickness. Films were also covered with paper to 
protect from dust contamination but allow evaporation. The water was then allowed to 
evaporate and resulting films were carefully removed from the trays. The distribution of film 
components was then assessed using SEM and confocal microscopy. SEM was used to visualise 
the surfaces of the films, and confocal microscopy was used to take visual sections through the 
films. 
 
The enzyme-functionalised amyloid fibrils prepared during this research were highly 
heterogeneous, as shown in TEM images in Section 4.7. Before mechanical testing could be 
carried out on the functionalised films to test the effect of the addition of amyloid fibrils to the 
film properties, it was important to assess the degree of dispersion of the functionalised amyloid 
fibrils within the film. If its components are not evenly distributed, the film will contain points 
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of weakness, and the results of any mechanical testing will be affected (Mark Staiger, Personal 
Communication). Scanning electron microscopy (SEM) was used to view the surface of the film 
and confocal microscopy was used to view the distribution of constituents by taking image 
slices through the film. SEM is frequently used to investigate phase behaviour of blends of 
synthetic polymers and biopolymers, providing useful information on miscibility of polymers 
(Aoi et al. 2000a; Aoi et al. 2000b). Confocal microscopy has been used in a similar way for 
studying the phase-separated structures of polymer blends including PVOH hydrogel blends 
(Fergg et al. 2001; Jinnai et al. 2001). 
 
 
6.2.1 Scanning electron microscopy of functionalised film 
 
SEM was used to image the surface topography of the functionalised film. This technique has 
been used previously on PVOH/gelatin/chitosan blend films to visualise the surface morphology 
(Chen et al. 2008). Representative images from the SEM studies are given in Figure 6.1. 
Imaging the surface of the film is a useful tool for investigating the features of the film. These 
results show a variety of features, which may be influenced by the constituents of the film.  
 
Without addition of other constituents, PVOH film had a relatively smooth surface at 1,000 x 
magnification, which remained unchanged upon addition of GA (Figure 6.1A, B). A small 
amount of dust and other contaminants were visible on the surface of the films. Upon addition 
of GOD to the PVOH films, there was the appearance of small voids, possibly due to bubbles in 
the film when casting (Figure 6.1C). These voids were accentuated upon addition of GA (Figure 
6.1D). This effect could be due to increased phase separation of film constituents due to 
hydrophobicity introduced by cross-linking.  
 
When insulin amyloid fibrils were added to PVOH film, there was a large amount of surface 
heterogeneity, with small bubble-like formations on the surface of the film (Figure 6.1E). These 
bubbles increased in size dramatically upon addition of GA (Figure 6.1F). The addition of GOD 
and insulin amyloid fibrils to the PVOH film produced a smoother film surface than amyloid 
fibrils alone, with rough patches of surface, and the addition of GA had little effect on the 
surface (Figure 6.1G, H). The addition of crystallin amyloid fibrils to PVOH produced an 
interesting surface, with long, thin indentations visible (Figure 6.1K). This effect was not seen 
in any of the other film samples (Figure 6.1I, K and L).  
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Figure 6.1 
Representative SEM images of film surfaces. Film surfaces were imaged at 1,000 x magnification in 
duplicate. 2.5% PVOH (A), 2.5% PVOH and 2 mM GA (B), 2.5% PVOH and 1.7 mg/ml GOD (C), 2.5% 
PVOH, 1.7 mg/ml GOD and 2 mM GA (D), 2.5% PVOH, and 1.5 mg/ml insulin amyloid fibrils (E), 2.5% 
PVOH, 1.5 mg/ml insulin amyloid fibrils and 2 mM GA (F), 2.5% PVOH, 1.5 mg/ml insulin amyloid 
fibrils and 1.7 mg/ml GOD (G), 2.5% PVOH, 1.5 mg/ml insulin amyloid fibrils, 1.7 mg/ml GOD and 2 
mM GA (H), 2.5% PVOH and 1.5 mg/ml crystallin amyloid fibrils (I), 2.5% PVOH, 1.7 mg/ml crystallin 
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amyloid fibrils and 2 mM GA (J), 2.5% PVOH, 1.5 mg/ml crystallin amyloid fibrils and 1.7 mg/ml GOD 
(K), and 2.5% PVOH, 1.5 mg/ml crystallin amyloid fibrils, 1.7 mg/ml GOD and 2 mM GA (L).  
 
The surfaces of the crystallin amyloid fibrils, GA and PVOH film and the crystallin amyloid 
fibrils, GOD, GA and PVOH film (Figure 6.1J and L, respectively) were very similar, with a 
clustered rough surface, whereas the crystallin amyloid fibrils, GOD and PVOH film has a 
comparatively smooth surface.  
 
The PVOH films have very different surfaces, where some features can be explained by the film 
constituents. The bubble-like formations could be phase-separation of constituents, caused by 
hydrophobic interactions between PVOH cross-linked by excess GA and water, or where 
hydrophobic amino acids cannot interact with hydrophilic PVOH (Mendieta-Taboada et al. 
2008). The surfaces of these films are thus rough and highly variable. Therefore, more analysis 
of film composition and dispersal of constituents is needed before meaningful results can be 
obtained by mechanical testing methods.    
 
 
6.3 Confocal microscopy 
 
As discussed in Section 1.8, GOD contains one FAD cofactor per monomer (Wilson and Turner 
1992). FAD has an intrinsic fluorescence with an emission at 530 nm (De Luca et al. 2007). 
This is useful when viewing the enzyme using confocal microscopy, as the FAD cofactor emits 
fluorescence, which has previously been used to assess GOD enzyme loading in immobilisation 
experiments (Park et al. 2004). Amyloid fibrils are reported to have some intrinsic fluorescence, 
which could be associated with constituent amino acid residues; however, the reason for this 
remains unknown (del Mercato et al. 2007).  
 
The film samples and associated controls were mounted on slides and viewed using confocal 
microscopy as described in Section 2.5.2. Confocal microscopy was used to visualise 
fluorescence emitted by the FAD cofactor of the GOD enzyme and intrinsic fluorescence of the 
amyloid fibrils, in order to ascertain the spatial distribution of these constituents in the film. 
 
The confocal images in Figure 6.2 show two types of fluorescence patterns, localised and 
diffuse fluorescence. The PVOH and PVOH and GA films (Figure 6.2A and B, respectively), 
did not exhibit any fluorescence. Upon addition of GOD, light spots of localised fluorescence 
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were visible (Figure 6.2C). Because individual GOD molecules are too small to be visualised at 
this magnification (Hecht et al. 1993), it is likely that the GOD was not homogeneously mixed 
throughout the PVOH film, resulting in pockets of GOD, where the combined fluorescence was 
large enough to be visible. The addition of GA produced more abundant localised fluorescence 
(Figure 6.2D). Glutaraldehyde has previously been used to increase auto-fluorescence of 
proteins upon cross-linking (Fester et al. 2008). This may be due to pyridinium links formed 
during the cross-linking reaction (Meade et al. 2003).  
 
The PVOH and insulin amyloid fibrils film (Figure 6.2E) showed a more diffuse fluorescence 
pattern than the fluorescence of the PVOH and GOD film. This was mirrored in the PVOH and 
crystallin amyloid fibrils film image (Figure 6.2I). Similarly, the addition of GA increased the 
diffuse fluorescence pattern of both PVOH and insulin amyloid fibril and PVOH and crystallin 
amyloid fibril film samples (Figure 6.2F and J, respectively). The increase in fluorescence of 
both GOD and insulin amyloid fibrils upon addition of GA is consistent with an auto-
fluorescent pyridinium reaction product of GA with amine residues on the enzyme and the 
amyloid fibrils, also seen in Chapter Four.   
 
In the PVOH, insulin amyloid fibrils and GOD film sample (Figure 6.2G), there is a mixture of 
diffuse and localised fluorescence. This is consistent with a mixture of the PVOH and GOD 
film and the PVOH and insulin amyloid fibrils film, allowing the distribution of GOD and 
amyloid fibrils to be assessed together. The fluorescence of the sample was again greatly 
enhanced by addition of GA. The same trend was seen in the PVOH, crystallin amyloid fibrils 
and GOD and PVOH, crystallin amyloid fibrils, GOD and GA films (Figure 6.2K and L, 
respectively). However, the fluorescence produced by crystallin amyloid fibrils and GA was 
much more intense than the fluorescence produced by insulin amyloid fibrils and GA, which 
leads to oversaturation of the images. This could be because bovine crystallin has more free 
amine groups than bovine insulin, due to having a larger number of lysine residues in its amino 
acid sequence, which would be able to form more fluorescent adducts with the GA, consistent 
with the results seen in Chapter Four. 
 
These confocal microscopy results indicated that in the prepared PVOH films, GOD produced a 
localised fluorescence pattern, and both insulin and crystallin amyloid fibrils produced a diffuse 
fluorescence pattern. Like the SEM, confocal microscopy also indicated heterogeneous mixtures 
and/or phase-separation in film samples.  
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Figure 6.2 
Confocal images of PVOH film samples. Light emission images are representative of two film replicates 
and taken near the median focal plane of samples 2.5% PVOH (A), 2.5% PVOH and 2 mM GA (B), 2.5% 
PVOH and 1.7 mg/ml GOD (C), 2.5% PVOH, 1.7 mg/ml GOD and 2 mM GA (D), 2.5% PVOH, and 1.5 
mg/ml insulin amyloid fibrils (E), 2.5% PVOH, 1.5 mg/ml insulin amyloid fibrils and 2 mM GA (F), 2.5% 
PVOH, 1.5 mg/ml insulin amyloid fibrils and 1.7 mg/ml GOD (G), 2.5% PVOH, 1.5 mg/ml insulin 
amyloid fibrils, 1.7 mg/ml GOD and 2 mM GA (H), 2.5% PVOH and 1.5 mg/ml crystallin amyloid fibrils 
(I), 2.5% PVOH, 1.7 mg/ml crystallin amyloid fibrils and 2 mM GA (J), 2.5% PVOH, 1.5 mg/ml crystallin 
amyloid fibrils and 1.7 mg/ml GOD (K), and 2.5% PVOH, 1.5 mg/ml crystallin amyloid fibrils, 1.7 mg/ml 
GOD and 2 mM GA (L).  
 
To establish whether the amyloid fibrils added to the PVOH film retained their fibrillar nature 
during film formation, ThT was added to the films prior to casting. PVOH films containing ThT 
also showed dark spots of no fluorescence (Figure 6.3A). This could be due to incomplete 
mixing or phase separation of ThT throughout the film, leaving pockets of unmixed PVOH. The 
pockets created by the addition of ThT make it difficult to visualise the fluorescence from 
individual constituents, such as GOD. 
 
Despite the low magnification of confocal microscopy in comparison to TEM (630 x and 89,000 
x respectively) used to visualise amyloid fibrils, long, thin fibrillar structures were visible in the 
PVOH, ThT and insulin amyloid fibrils film samples. These fibrillar structures are larger in size 
than the amyloid fibrils viewed in the TEM images, which had a width of 6 nm (Section 3.2 
(Figure 2) and Section 3.5 (Figure 6A)). This is consistent with previous reports of ThT binding 
in channels along the length of the fibril (Krebs et al. 2005). This is an interesting result as it 
implies that amyloid fibrils are still intact in the PVOH film, and shows the clustered 
distribution of fibrils throughout the film. The background fluorescence of the film (Figure 
6.3A) is higher than in images without ThT (Figure 6.2A), due to the fluorescence spectrum of 
unbound ThT. Unbound ThT gives a fluorescence spectrum with an excitation/emission 
maximum of 385/445 nm, whereas bound ThT undergoes a spectral shift with an 
excitation/emission maxima at 450/482 nm (LeVine III 1993). Therefore, when excited at 405 
nm, fluorescence from both bound and unbound ThT is visible at the wavelengths detected by 
the confocal microscope (430 - 520 nm).  
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Figure 6.3 
Confocal microscopy of PVOH film samples containing ThT. Light emission images are representative 
of two film replicates and taken near the median focal plane of samples 2.5% PVOH and ThT (A) and 
2.5% PVOH, ThT, and 1.5 mg/ml insulin amyloid fibrils (B). 
 
Before mechanical testing can be carried out on the films, methods must be developed to ensure 
homogeneous mixing, removing weaknesses in the film and producing meaningful mechanical 
testing results in tests such as dynamic mechanical analysis (DMA). DMA is the application of 
oscillating force to a film sample in order to measure the response of the material. DMA testing 
can then determine the mechanical properties and detect molecular motion, so that morphology 
relationships such as crystallinity can be developed (Aoi et al. 2000a; Park et al. 2001). This 
knowledge is important for use in film applications, and is thus important for future studies 
(Mendieta-Taboada et al. 2008). A possible method to improve dispersion could involve 
mechanically stirring films before casting or heat pressing films, which are methods commonly 
used to facilitate even dispersal of film components (Yang et al. 2004; Ljungberg and Wesslén 
2005; Mendieta-Taboada et al. 2008). However, a heat pressing method would need 
development, as a disadvantage of heat pressing films is the high temperatures reached in the 
hot press of around 200°C, which would denature the GOD enzyme (Yang et al. 2004; 
Ljungberg and Wesslén 2005).  
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6.4 Activity assay 
 
Before the functionalised film can be developed for any applications, the retention of enzyme 
activity in the film system must be established. The Amplex Red assay was used to qualify 
GOD activity, as described in Section 2.3. The exact activity of GOD in the PVOH film is 
difficult to quantify, due to uneven dispersion throughout the film; however, the visual colour 
change (Section 1.9) gave a qualitative measure. At the time of publication, GOD was still 
active in the film after storage at room temperature for 6 months, as qualitatively indicated by a 
pink colour change in the presence of Amplex Red reaction mixture. 
 
 
6.5 Antibacterial effect of film  
 
Hydrogen peroxide produced by GOD is known to have a natural antibacterial and antifungal 
action when produced by some insect and fungal species (Taormina et al. 2001; Wong et al. 
2008).  Thus, if GOD is active when attached to amyloid fibrils and incorporated into a PVOH 
film, it would be expected to retain antimicrobial activity. GOD has been encapsulated in 
PVOH using glutaraldehyde in previous research and has retained antimicrobial activity (Wong 
and Abdul-Aziz 2008). Thus, because GOD was still active when attached to amyloid fibrils 
using glutaraldehyde, it would be expected to retain antimicrobial activity when incorporated 
into a PVOH film system. Functionalised film samples and controls were tested for 
antimicrobial activity against the bacterium E. coli.  E. coli normally colonises the human 
gastrointestinal tract; however, pathogenic strains are able to cause a broad spectrum of 
diseases, and even non-pathogenic E. coli can cause infection in immunocompromised hosts 
(Nataro and Kaper 1998). Thus an effective antibacterial agent is invaluable for use in food 
packaging, providing protection from E. coli infection. E. coli is also a good model for 
demonstrating antibacterial activity, as much is known about the bacterium. Once the 
antibacterial activity of the film against E. coli is demonstrated, the antibacterial effect of the 
film on other bacteria can be investigated. 
 
Film samples were cut and placed on LB agar plates inoculated with a lawn of E. coli, as 
described in Section 2.6.1. This allowed assessment of the effect of the functionalised film on 
the growth of the bacterium, where areas of restricted growth are seen as a halo around the film 
sample. The permeability of the functionalised film to glucose can was also assessed by using 
media with and without glucose, as PVOH film containing GOD and GA has been shown to be 
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permeable to low molecular weight substances such as glucose (Wong and Abdul-Aziz 2008). 
Representative photographs of the effect of film samples on E. coli growth are shown in Figure 
6.4. The halo effect is only seen in the film samples on plates containing glucose. This shows 
that the addition of amyloid fibrils does not affect the permeability of the functionalised PVOH 
films to glucose. 
 
 
Figure 6.4 
Effect of film samples on E. coli growth. PVOH film samples containing GOD and amyloid fibrils are 
located at the top and bottom of the plate, and PVOH samples are located at the left and right of each 
plate. E. coli was inoculated on LB medium (left) and LB medium containing 10 g/l glucose (right). 
 
The results of the functionalised amyloid fibril film samples and the associated controls are 
presented in Table 6.1, showing the film sample and whether the halo effect was produced with 
E. coli. The halo effect was produced in all film samples containing the GOD enzyme. This 
indicates that GOD has antibacterial activity in the PVOH film, including when attached to 
amyloid fibrils.  
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Table 6.1 
Effect of film samples on growth of E. coli. The film samples and their effect on E. coli growth are 
shown. 
 
 
Film Halo Effect Produced 
PVOH No 
PVOH and GA No 
PVOH and GOD Yes 
PVOH, GOD and GA Yes 
PVOH and insulin amyloid fibrils No 
PVOH, insulin amyloid fibrils and GA No 
PVOH, insulin amyloid fibrils and GOD Yes 
PVOH, insulin amyloid fibrils, GOD and GA Yes 
PVOH and crystallin amyloid fibrils No 
PVOH, crystallin amyloid fibrils and GA No 
PVOH, crystallin amyloid fibrils and GOD Yes 
PVOH, crystallin amyloid fibrils, GOD and GA Yes 
 
 
6.6 Antimicrobial effect of film 
 
This film was tested for antifungal activity against the fungi Fusarium, Penicillium and 
Rhizopus. Penicillium and Rhizopus are both commonly found fungi involved in food spoilage. 
Fusarium is a plant fungus that is known to cause rot in roots and shoots of crops such as rye 
and wheat (Miedaner 1997). Thus these fungal species are known to be the main contaminants 
of bread (Gerez et al. 2009). The antifungal experiments were conducted in a similar way to the 
antibacterial experiments, where film samples were placed on an agar plate inoculated with a 
fungal species. A halo of restricted growth of the fungus was expected if an antifungal activity 
was present.  
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Table 6.2 
Effect of film samples on fungal growth. Film samples are listed, with their inhibitory effect on the fungi 
Fusarium, Penicillium and Rhizopus given (yes/no). 
 
 
Film Halo Effect Produced 
 Fusarium Penicillium Rhizopus
PVOH No No No 
PVOH and GA No No No 
PVOH and GOD No No No 
PVOH, GOD and GA No No No 
PVOH and insulin amyloid fibrils No No No 
PVOH, insulin amyloid fibrils and GA No No No 
PVOH, insulin amyloid fibrils and GOD No No No 
PVOH, insulin amyloid fibrils, GOD and GA No No No 
PVOH and crystallin amyloid fibrils No No No 
PVOH, crystallin amyloid fibrils and GA No No No 
PVOH, crystallin amyloid fibrils and GOD No No No 
PVOH, crystallin amyloid fibrils, GOD and GA No No No 
 
 
None of the film samples inhibited growth of the fungi. This could be due to the production of 
catalase by the fungi. Catalase uses hydrogen peroxide as a substrate, thus removing it before an 
inhibitory effect on growth of the fungi can occur (Wu et al. 1995). This effect could be reduced 
by co-immobilising another enzyme such as lactoperoxidase, which uses hydrogen peroxide in 
the generation of other products with antimicrobial properties (Vartiainen et al. 2005). 
 
A common issue encountered during antimicrobial film experiments was the growth of 
contaminants, specifically the growth of a pink species, identified as a yeast (Craig Galilee, 
Personal Communication). Reduction in contaminants can be achieved by sterilising the film. 
Methods of sterilisation include moist heat, dry heat, gases, filtration and radiation. A major 
problem for sterilisation using moist heat is the high solubility of the PVOH film in water, due 
to the high affinity of the hydroxyl groups in PVOH for water. This could be altered by creating 
strong hydrogen bonding between intramolecular and intermolecular hydroxyl groups, greatly 
inhibiting the solubility of PVOH in water (Kim et al. 2007). Dry heat cannot be used for the 
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PVOH film samples due to the loss of enzymatic activity of GOD at temperatures above 60 °C, 
and filtration cannot be used to sterilise the PVOH before addition of other film constituents due 
to the high viscosity of the liquid. UV radiation is very effective at removing the pink yeast; 
however, the impact of UV radiation on the activity of the GOD enzyme is unknown. A gas 
such as ethylene oxide would be ideal for sterilising the PVOH films in further experiments, 
provided that the effect of exposure on GOD activity is investigated prior to film sterilisation.  
 
Another interesting factor encountered during the antimicrobial experiments was the curling of 
film pieces, most notably in the insulin amyloid fibrils and GA film samples. When placed on 
the agar plate, these film samples would curl up away from the agar, as opposed to other film 
samples which would remain in place on the agar plate. This suggests that excess GA in the film 
has a cross-linking effect on the PVOH. This would cause the PVOH to become more 
hydrophobic, resulting in film curling away from the hydrophilic agar plate. This could also be a 
drying effect. A solution to this problem could be to quench GA cross-linking before addition to 
the PVOH film.  
 
 
6.7 Conclusion 
 
The incorporation of immobilised GOD into a PVOH film system yielded a novel 
bionanomaterial, with well characterised dispersal of constituents and retention of GOD activity 
and thus antimicrobial activity. Further work on the dispersion of the nanoscaffold into the film 
matrix is required in order to move this research closer to materials of commercial utility. 
Despite this, the addition of a GOD functionalised amyloid fibril scaffold to a PVOH film 
provides a good ‘proof of concept’ bionanomaterial, based on enzyme immobilisation onto 
amyloid fibrils.  
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7. CHAPTER SEVEN - SUMMARY AND 
CONCLUSIONS 
 
 
Amyloid fibrils have considerable potential for use in the creation of bionanomaterials. To 
ensure feasibility for the use of amyloid fibrils in the production of new materials in 
bionanotechnology, the amyloidogenic protein must be readily available and inexpensively 
sourced (Waterhouse and Gerrard 2004). This thesis aimed to investigate whether amyloid 
fibrils could be prepared from a crude agricultural waste protein, bovine lens crystallin, and 
functionalised via attachment of GOD. It also explored the incorporation of this functionalised 
enzyme scaffold into a film system in the creation of a novel bionanomaterial. Using PVOH as a 
model film, the ability to incorporate an amyloid fibril scaffold with GOD activity was assessed.  
 
Initially, the ability to form amyloid fibrils from a crude mixture of bovine lens crystallins was 
investigated, building on previous work by Garvey et al. crystallin proteins were purified using 
size exclusion chromatography and the ability of the purified fractions to form amyloid fibrils 
was assessed by TEM (Garvey et al. 2009). Long, thin structures characteristic of amyloid 
fibrils were visible in only the α- and βH-crystallins fractions. The method of crude crystallin 
extraction was modified to give a higher crude protein yield. This method produced a higher 
proportion of long, straight fibrils in a scaffold formation ideal for enzyme immobilisation 
directly from a crude extract, without purification, and was thus used for further experiments.  
 
The effect of proteolytic digestion and increase in pH on crude crystallin samples was also 
investigated. Proteolytic digestion removed the short, curly structures, leaving a scaffold of 
long, straight fibrils. An increase in environmental pH caused the amyloid fibrils to clump 
together, and individual fibrils became difficult to visualise. This effect could have been due to 
either increase of pH or addition of salt. However, this is useful information when incorporating 
amyloid fibrils into bionanomaterials.   
 
Three different methods of attaching GOD to amyloid fibrils were then assessed. The first 
method of attaching GOD to amyloid fibrils using GA was established, and the effect of this 
immobilisation on the integrity of the amyloid fibrils was assessed by TEM. Results showed no 
Chapter Seven - Summary and conclusions 128 
 
change of amyloid fibril morphology upon cross-linking, with both amyloid fibrils and enzyme 
aggregate visible. GOD retained activity upon immobilisation to both insulin and crystallin 
amyloid fibrils, and separation techniques such as electrophoresis and centrifugation were then 
used to assess the degree of cross-linking. Electrophoresis of cross-linked samples indicated that 
cross-linking was occurring and this result was corroborated with centrifugation data. 
Centrifugation was a more efficient method of separating cross-linked material, and showed a 
non-covalent interaction between amyloid fibrils and GOD. 
 
Two other methods of enzyme attachment were then investigated; deglycosylation of GOD and 
attachment via glutaraldehyde cross-linking and attachment via periodate oxidation of the 
carbohydrate shell. The efficacy of these attachment methods were tested by electrophoresis and 
centrifugation. Both of these methods were successful in attaching GOD to amyloid fibrils; 
however, no additional attachment effect was seen, and thus glutaraldehyde cross-linking to 
native GOD was chosen for further experiments.  
 
PVOH films were manufactured with the addition of functionalised insulin amyloid fibrils or 
functionalised crystallin amyloid fibrils using a solution casting method (Rao 2008). SEM and 
confocal microscopy studies revealed an uneven distribution of film components. ThT was then 
added to the casting solutions to confirm the integrity of amyloid fibrils in the films, viewed 
using confocal microscopy. Immobilised GOD retained activity when incorporated into the 
PVOH film, as determined by antibacterial experiments, where growth of E. coli was inhibited 
by film samples containing GOD-functionalised amyloid fibrils. No growth inhibition of 
Fusarium, Rhizopus or Penicillium was observed in antifungal experiments. 
 
Following this established proof of concept, future work on the addition of functionalised 
enzyme scaffolds to film systems should include the development of methods to evenly disperse 
film components, test the effect of the addition of amyloid fibrils on the mechanical properties 
of the film and optimise a commercially viable film system (Ljungberg and Wesslén 2005; 
Mendieta-Taboada et al. 2008). The model of GOD immobilisation to amyloid fibrils also has 
the potential to be applied to other enzymes. Functionalised amyloid fibril polymer blends have 
the potential to create novel bionanomaterials with a wide range of enzymatic activities and thus 
a large number of potential applications.  
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